<SEC-DOCUMENT>0001564590-20-006078.txt : 20200225
<SEC-HEADER>0001564590-20-006078.hdr.sgml : 20200225
<ACCEPTANCE-DATETIME>20200224173651
ACCESSION NUMBER:		0001564590-20-006078
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20200221
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200225
DATE AS OF CHANGE:		20200224

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BROWN & BROWN, INC.
		CENTRAL INDEX KEY:			0000079282
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE AGENTS BROKERS & SERVICES [6411]
		IRS NUMBER:				590864469
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13619
		FILM NUMBER:		20645784

	BUSINESS ADDRESS:	
		STREET 1:		220 S. RIDGEWOOD AVE.
		CITY:			DAYTONA BEACH
		STATE:			FL
		ZIP:			32114
		BUSINESS PHONE:		386-252-9601

	MAIL ADDRESS:	
		STREET 1:		220 S. RIDGEWOOD AVE.
		CITY:			DAYTONA BEACH
		STATE:			FL
		ZIP:			32114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BROWN & BROWN, INC
		DATE OF NAME CHANGE:	20171108

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BROWN & BROWN INC
		DATE OF NAME CHANGE:	19990623

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	POE & BROWN INC
		DATE OF NAME CHANGE:	19930827
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bro-8k_20200221.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-02-24T19:21:07.1424831+00:00 -->
<!-- Version            : 5.0.1.321 -->
<!-- Package ID         : 63bf4c34220d45a2b87f6e841022accc -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:bro="http://www.bbinsurance.com/20200221" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
bro-8k_20200221.htm
</title>
</head>
<!-- NG Converter v5.0.2.38 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0000079282_20200221_20200221">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0000079282_20200221_20200221">0000079282</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="bro-20200221.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0000079282_20200221_20200221">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000079282</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-02-21</xbrli:startDate>
					<xbrli:endDate>2020-02-21</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0000079282_20200221_20200221">8-K</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of The Securities Exchange Act of 1934</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported):<span style="font-weight:normal;"> </span><ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0000079282_20200221_20200221" format="ixt:datemonthdayyearen">February 21, 2020</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0000079282_20200221_20200221">BROWN&#160;&#38; BROWN, INC.</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="width:32.08%;"></td>
<td style="width:2.13%;"></td>
<td style="width:31.81%;"></td>
<td style="width:2.12%;"></td>
<td style="width:31.87%;"></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0000079282_20200221_20200221" format="ixt-sec:stateprovnameen">Florida</ix:nonNumeric></p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0000079282_20200221_20200221">001-13619</ix:nonNumeric></p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0000079282_20200221_20200221">59-0864469</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of incorporation)</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0000079282_20200221_20200221">220 South Ridgewood Avenue</ix:nonNumeric>, <ix:nonNumeric id="F_000010" name="dei:EntityAddressCityOrTown" contextRef="C_0000079282_20200221_20200221">Daytona Beach</ix:nonNumeric>, <ix:nonNumeric id="F_000011" name="dei:EntityAddressStateOrProvince" contextRef="C_0000079282_20200221_20200221" format="ixt-sec:stateprovnameen">Florida</ix:nonNumeric> <ix:nonNumeric id="F_000012" name="dei:EntityAddressPostalZipCode" contextRef="C_0000079282_20200221_20200221">32114</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices) (Zip Code)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric id="F_000013" name="dei:CityAreaCode" contextRef="C_0000079282_20200221_20200221">386</ix:nonNumeric>) <ix:nonNumeric id="F_000014" name="dei:LocalPhoneNumber" contextRef="C_0000079282_20200221_20200221">252-9601</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">N/A</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report.)</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.48%;">
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000015" name="dei:WrittenCommunications" contextRef="C_0000079282_20200221_20200221" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96.52%;">
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
<tr>
<td valign="top" style="width:3.48%;">
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:SolicitingMaterial" contextRef="C_0000079282_20200221_20200221" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96.52%;">
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
<tr>
<td valign="top" style="width:3.48%;">
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:PreCommencementTenderOffer" contextRef="C_0000079282_20200221_20200221" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96.52%;">
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
<tr>
<td valign="top" style="width:3.48%;">
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0000079282_20200221_20200221" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96.52%;">
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:42.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="middle" style="width:20.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol(s)</p></td>
<td valign="middle" style="width:36.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="middle" style="width:42.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:Security12bTitle" contextRef="C_0000079282_20200221_20200221">Common Stock, $0.10 Par Value</ix:nonNumeric></p></td>
<td valign="middle" style="width:20.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:TradingSymbol" contextRef="C_0000079282_20200221_20200221">BRO</ix:nonNumeric></p></td>
<td valign="middle" style="width:36.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:SecurityExchangeName" contextRef="C_0000079282_20200221_20200221" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule&#160;405 of the Securities Act of 1933 or Rule&#160;12b-2 of the Securities Exchange Act of 1934.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0000079282_20200221_20200221" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160; </span><span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;</span><span style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5</span><span style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.02</span><span style="font-weight:normal;margin-left:36pt;"></span><span style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Election of Directors&#59; Appointment of Certain Officers&#59; Compensatory</span><span style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Arrangements of Certain Officers</span><span style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective February 24, 2020, Anthony T. Strianese, Executive Vice President and President of the Wholesale Brokerage Segment of Brown &#38; Brown, Inc. (the "Company"), has taken a temporary medical leave of absence. Other executive officers of the Company will assume his management duties during his absence and will remain in their current positions while carrying out such additional responsibilities.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)<span style="margin-left:36pt;"></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:12pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Performance Stock Award Grants</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 21, 2020, t<span style="color:#000000;">he Compensation Committee of the Board of Directors (the &#8220;Compensation Committee&#8221;) of the Company </span>authorized and approved grants of shares of performance-based restricted stock under the 2019 Stock Incentive Plan to, among others, certain of the Company's named executive officers. Certain of these restricted shares (collectively, the &#8220;PSA Shares&#8221;) are subject to certain performance, employment, change of control, and death and disability conditions, and will vest on February 21, 2025. The amounts of PSA Shares granted to the Company's named executive officers are as follows: <span style="color:#000000;">J. Powell Brown &#8211; 46,382&#59; R. Andrew Watts &#8211; 10,822&#59; J. Scott Penny &#8211; 7,730&#59; Anthony T. Strianese &#8211; 7,730&#59; Chris L. Walker &#8211; 7,730</span>.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A copy of a form of the Performance Stock Award Agreement pursuant to which these grants were made is attached as Exhibit 10.1 to this Current Report on Form 8-K.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:12pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Restricted Stock Award Grants</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 21, 2020, the Compensation Committee also authorized and approved grants of shares of time-based restricted stock under the 2019 Stock Incentive Plan to, among others, certain of the Company's named executive officers. Certain of these restricted shares (collectively, the &#8220;RSA Shares&#8221;) are subject to certain employment, change of control, and death and disability conditions, and will vest on February 21, 2025. The amounts of RSA Shares granted to the Company's named executive officers are as follows: <span style="color:#000000;">J. Powell Brown &#8211; 15,460&#59; R. Andrew Watts &#8211; 3,607&#59; J. Scott Penny &#8211; 2,576&#59; Anthony T. Strianese - 2,576&#59; Chris L. Walker - 2,576</span>.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A copy of a form of Restricted Stock Award Agreement, pursuant to which these grants were made, is attached as Exhibit 10.2 to this Current Report on Form 8-K.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:12pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Annual Cash Incentive for 2020 </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 21, 2020, t<span style="color:#000000;">he Compensation Committee </span>adopted the annual cash incentive for 2020 for the Company&#8217;s executive officers, including the named executive officers, pursuant to which they are eligible to receive a cash incentive payment based on the achievement of certain performance objectives in 2020. The terms of the annual cash incentive are not contained in a formal written document.</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each named executive officer&#8217;s annual cash incentive payment amount will consist of three components (the calculation of which may be adjusted by the Compensation Committee, at its discretion, to exclude the effect of items that are unusual in nature or infrequently occurring), which are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">The first component, which will affect 40% of the 2020 cash incentive amount, is based on specified organic revenue growth targets, which, for named executive officers whose responsibilities encompass the Company as a whole rather than being tied to a particular division, will be calculated based upon the organic revenue growth of the Company as a whole, and for named executive officers with divisional operational responsibilities, will be calculated based upon the organic revenue growth of the offices for which each such executive officer has oversight responsibility.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">The second component, which will affect 40% of the 2020 cash incentive amount, will be determined based upon performance of the Company&#8217;s EBITDAC margin (&#8220;EBITDAC Margin&#8221;), which is the Company&#8217;s income before income taxes less amortization, depreciation, interest, and the change in estimated acquisition earn-out payables, divided by total revenues. </p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">The third component, which will affect 20% of the 2020 cash incentive amount, will be linked to the achievement of personal objectives of the named executive officer as determined by the Compensation Committee.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each of the components described above contemplates a minimum payout of 0% of each named executive officer&#8217;s target cash incentive <span style="color:#000000;">amount and a maximum payout of 200% of each named executive officer&#8217;s target cash incentive amount (in the case of Mr. Penny, however, the foregoing components are weighted 25% based on specified organic revenue growth targets based upon the organic revenue growth of the Company as a whole, 25% based upon EBITDAC Margin, and 50% based on achievement of personal objectives). The target cash incentive amounts for</span> our named executive officers for 2020 are as follows: J. Powell Brown - $2,000,000&#59; R. Andrew Watts - $700,000&#59; J. Scott Penny - $900,000&#59; Anthony T. Strianese - $900,000&#59; Chris L. Walker - $1,000,000.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.46%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.01.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><span style="font-weight:normal;"></span>Financial Statements and Exhibits.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">Exhibits</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following exhibit is furnished herewith:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:8.76%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit&#160;No.</p></td>
<td valign="middle" style="width:0.9%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:90.34%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="middle" style="width:8.76%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:0.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:90.34%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="width:8.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="middle" style="width:0.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:90.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="bro-ex101_6.htm"><span style="text-decoration:underline;">Form of Performance Stock Award Agreement under the 2019 Stock Incentive Plan</span></a></p></td>
</tr>
<tr>
<td valign="middle" style="width:8.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:0.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:90.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="width:8.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="middle" style="width:0.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:90.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="bro-ex102_7.htm"><span style="text-decoration:underline;">Form of Restricted Stock Award Agreement under the 2019 Stock Incentive Plan</span></a></p></td>
</tr>
<tr>
<td valign="middle" style="width:8.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:0.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:90.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="width:8.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="middle" style="width:0.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:90.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL for the cover page of this Current Report on Form 8-K</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: February 24, 2020</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&#160;</p>
<div style="align:right;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:50%;">
<tr>
<td colspan="3" valign="middle" style="width:37%;">
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="width:2%;">
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:1%;">
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:37%;">
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:37%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BROWN &#38; BROWN, INC.</p></td>
</tr>
<tr>
<td valign="middle" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:37%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:37%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="width:2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="middle" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:37%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/S/ Robert W. Lloyd</p></td>
</tr>
<tr>
<td valign="middle" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;text-align:left;">&#160;</p></td>
<td valign="middle" style="width:37%;">
<p style="margin-bottom:0pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Robert W. Lloyd</p>
<p style="margin-bottom:0pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Executive Vice President, General Counsel</p>
<p style="margin-bottom:0pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and Secretary</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>bro-ex101_6.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
bro-ex101_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.38 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">BROWN &amp; BROWN, INC.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">PERFORMANCE STOCK AWARD AGREEMENT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">(Key Corporate Leaders / Profit Center Leaders / Other Leaders)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">This Performance Stock Award Agreement (this &#8220;Agreement&#8221;) is entered into as of ______________, 20__ (the &#8220;Date of Grant&#8221;), between Brown &amp; Brown, Inc., a Florida corporation (together with its subsidiaries, the &#8220;Company&#8221;) and _________ (the &#8220;Grantee&#8221;), pursuant to the terms and conditions of the Brown &amp; Brown, Inc. 2019 Stock Incentive Plan, as amended (the &#8220;Plan&#8221;). Any term capitalized but not defined in this Agreement will have the meaning set forth in the Plan.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">The Plan provides to the Compensation Committee of the Board of Directors of the Company (the "Committee") the discretion and authority to grant Awards of shares of the common stock of the Company, par value $.10 per share (the &#8220;Common Stock&#8221;), contingent on transferability restrictions, vesting conditions, and additional terms and conditions provided by the Committee. The Plan identifies such an Award as a Restricted Stock Award. In addition, the Plan provides to the Committee the discretion and authority to specify performance-based conditions for the awarding of shares under a Restricted Stock Award, and identifies a Restricted Stock Award with such performance-based conditions as a Performance-Based Award. Pursuant to the terms of the Plan, the Committee desires to grant a Performance-Based Restricted Stock Award to the Grantee effective as of the Date of Grant. The Grantee desires to accept the Performance-Based Restricted Stock Award and agrees to be bound by the terms and conditions of the Plan and this Performance Stock Award Agreement. Accordingly, the Company and the Grantee hereby agree to the restrictions, terms, and conditions set forth below.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <font style="margin-left:36pt;"></font><font style="font-weight:bold;">1.</font><font style="font-weight:bold;margin-left:36pt;">Grant</font><font style="font-weight:bold;"> of Performance Shares.</font> The Company grants to the Grantee _____________ (________) shares of Common Stock (the &#8220;Performance Shares&#8221;). For purposes of this Agreement, the Performance Shares are divided into two (2) portions (each, a "Tranche"). Fifty percent (50%) of the Performance Shares will be &#8220;Tranche 1 Performance Shares&#8221; and fifty percent (50%) of the Performance Shares will be &#8220;Tranche 2 Performance Shares.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <font style="margin-left:36pt;"></font><font style="font-weight:bold;">2.</font><font style="font-weight:bold;margin-left:36pt;">Performance</font><font style="font-weight:bold;"> Conditions for Awarding of Performance Shares.</font> Except as otherwise provided in Section 4 of this Agreement in the event of a Change in Control or the termination of the Grantee's employment with the Company as a result of death or Disability, the percentages, if any, of the Tranche 1 Performance Shares and the Tranche 2 Performance Shares that will be treated as awarded (the "Awarded Performance Shares"), and therefore eligible to become vested and nonforfeitable in accordance with Section 3 of this Agreement, will be based on the level of achievement of the applicable performance goals set forth below during the three-year (3-year) period beginning on January 1, 20__, and ending on December 31, 20__ (the &#8220;Performance Period&#8221;), subject to the terms and conditions of this Section 2. </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"></font><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(a)</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Tranche </font><font style="font-weight:bold;">1</font><font style="font-weight:bold;"> Performance Shares - Organic </font><font style="font-weight:bold;">Revenue</font><font style="font-weight:bold;"> Growth</font><font style="font-weight:bold;"> Rate</font><font style="font-weight:bold;"> Condition.</font><font style="font-weight:bold;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The extent to which, if any, the Tranche 1 Performance Shares become Awarded Performance Shares </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be based upon the</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company's </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">verage </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">O</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rganic </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">G</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rowth</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Rate</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (as defined below)</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">during the Performance Period</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (the "Organic </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Growth </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rate </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Condition")</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The percentage, if any, of the Tranche 1 Performance Shares that become Awarded Performance Shares</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be determined in accordance with the following schedule: </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <font style="margin-left:36pt;">&nbsp;&nbsp;</font>&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:99.89%;">
<tr>
<td style="width:30.52%;"></td>
<td style="width:33.7%;"></td>
<td style="width:35.67%;"></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Performance Level</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Average Organic Revenue Growth Rate</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Awarded Percentage of </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Tranche 1 Performance Shares</p></td>
</tr>
<tr>
<td valign="top"  style=" border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maximum</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equal to or greater than __%</p></td>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">___%</p></td>
</tr>
<tr>
<td valign="top"  style=" border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">High Target</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__%</p></td>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">___%</p></td>
</tr>
<tr>
<td valign="top"  style=" border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Target</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__%</p></td>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">___%</p></td>
</tr>
<tr>
<td valign="top"  style=" border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Low Target</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__%</p></td>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ___%</p></td>
</tr>
<tr>
<td valign="top"  style=" border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Threshold</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__%</p></td>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ___%</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No Payout</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less than __%</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; 0%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the actual performance level of the Company's Average Organic Revenue Growth Rate falls in between any of the Performance Levels listed in the schedule above, the percentage of the Tranche 1 Performance Shares that become Awarded Performance Shares will be determined based on straight-line interpolation. The Company's "Average Organic Revenue Growth Rate" for the Performance Period will be determined by calculating the simple average of the Company&#8217;s Annual Organic Revenue Growth Rate (as defined below) over the Performance Period. The Company&#8217;s &#8220;Annual Organic Revenue Growth Rate&#8221; means the growth rate of Organic Revenue (as defined below) as reported in the Organic Revenue growth schedule prepared by the Corporate Finance department of the Company in support of the Company&#8217;s Annual Report on Form 10-K (or such comparable or equivalent schedule as may be prepared in accordance with legal or accounting rule requirements associated with future filings). &#8220;Organic Revenue&#8221; is defined as &#8220;core commissions and fees&#8221; less (i) the core commissions and fees earned for the first twelve months by newly-acquired operations and (ii) divested business (core commissions and fees generated from offices, books of business or niches sold or terminated during the comparable period). The term &#8220;core commissions and fees&#8221; excludes profit-sharing contingent commissions and guaranteed supplemental commissions ("GSCs"). The calculation of the Average Organic Revenue Growth Rate may be subject to adjustment for such items (for example, items that are unusual in nature or infrequently occurring) as, in the discretion of the Committee, are determined to be appropriately disregarded for all grantees whose agreements include an Organic Revenue Growth Rate Condition. Any such determination and approval made by the Committee will be final and binding upon the Grantee, the Company, their respective heirs, administrators, personal representatives, successors, assigns, and all other interested persons.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(b)</font><font style="font-weight:bold;margin-left:36pt;">Tranche </font><font style="font-weight:bold;">2 Performance Shares - EPS Condition. </font>The extent to which, if any, the Tranche 2 Performance Shares become Awarded Performance Shares will be based upon the Compound Annual Growth Rate (the "CAGR") of the Company's cumulative earnings per share during the Performance Period (the "EPS Condition"). The </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">percentage, if any, of the Tranche </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Performance Shares that </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">become A</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">warded</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Performance Shares</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be determined in accordance with the following schedule:</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:99.89%;">
<tr>
<td style="width:23.25%;"></td>
<td style="width:23.16%;"></td>
<td style="width:26.58%;"></td>
<td style="width:26.9%;"></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Performance Level</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Cumulative </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Earnings Per Share</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">CAGR</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Awarded Percentage of Tranche 2 Performance Shares</p></td>
</tr>
<tr>
<td valign="top"  style=" border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maximum</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equal to or greater than $____</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equal to or greater than ____%</p></td>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">___%</p></td>
</tr>
<tr>
<td valign="top"  style=" border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">High Target</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$____</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">____%</p></td>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">___%</p></td>
</tr>
<tr>
<td valign="top"  style=" border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Target</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$____</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">____%</p></td>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">___%</p></td>
</tr>
<tr>
<td valign="top"  style=" border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Low Target</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$____</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">____%</p></td>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ___%</p></td>
</tr>
<tr>
<td valign="top"  style=" border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Threshold</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$____</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">____%</p></td>
<td valign="top"  style=" border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ___%</p></td>
</tr>
<tr>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No Payout</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less than $____</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less than ____%</p></td>
<td valign="top"  style=" border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; 0%</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the actual performance level of the CAGR of the Company's earnings per share falls in between any of the Performance Levels listed in the schedule above, the percentage of the Tranche 2 Performance Shares that become Awarded Performance Shares will be determined based on straight-line interpolation. The CAGR of the Company's earnings per share for the Performance Period will be determined by comparison of the earnings per share, as adjusted by the Committee in its discretion to exclude the effect of certain items that were unusual in nature or infrequently occurring, for the twelve-month period ending December 31, 20__, that is $_______ per share, to the sum of the earnings per share for the twelve-month periods ending December 31, 20__, 20__, and 20__. For purposes of this Agreement, the Company's earnings per share will be calculated in accordance with generally accepted accounting principles recognized in the United States of America (&#8220;<font style="text-decoration:underline;">GAAP</font>&#8221;), except that such calculation will be (i) without regard to the impact of the line item in the Company&#8217;s income statement filed as part of the Company&#8217;s Annual Report on Form 10-K relating to the change in earn-out payments associated with acquisitions captioned &#8220;Change in estimated acquisition earnout payables,&#8221; required by Accounting Standards Codification Topic 805 - Business Combinations, or any comparable or equivalent amount reported in future filings pursuant to future accounting rule requirements, and (ii) subject to adjustment for such items (for example, items that are unusual in nature or infrequently occurring) as, in the discretion of the Committee, are determined to be appropriately disregarded for all grantees whose agreements include an EPS Condition.&nbsp;&nbsp; Any such determination and approval made by the Committee will be final and binding upon the Grantee, the Company, their respective heirs, administrators, personal representatives, successors, assigns, and all other interested persons.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(c)</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Procedure.</font> The applicable percentage, if any, of each Tranche will become Awarded Performance Shares on the date on which the Committee determines the level of achievement of the performance goal applicable to the Tranche (the "<font style="text-decoration:underline;">General Awarded Date</font>"), provided that the Grantee has been continuously employed by the Company since the Date of Grant. For the avoidance of doubt, the Committee's determinations of the levels of achievement of the performance goals for the Tranche 1 Performance Shares and the Tranche 2 Performance Shares may occur on different dates, and therefore the General Awarded Dates applicable to the Tranches are not required to be identical. Also for the avoidance of doubt, any reference in this Agreement to Awarded Performance Shares that does not include a reference to either of the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tranches </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be a reference to the Performance Shares in both Tranches that</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> become Awarded Performance Shares pursuant to either this Section 2 or Section 4 of the Agreement.</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Committee's determination </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be based on the actual level of achievement of the applicable performance goal, in accordance with the provisions of the Plan and this Agreement</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, including, without limitation, the provisions of the Plan and this Agreement relating to adjustment for items that are unusual in nature or infrequently occurring</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and the provisions of the Plan relating to the Committee&#8217;s authority and discretion to establish procedures</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for determination of the level of achievement</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The Committee's determination </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be final, binding, and conclusive on all persons, including but not limited to the Company and the Grantee. The Grantee </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> not be entitled to any claim or recourse if any action or inaction by the Company, or any other circumstance or event, including any circumstance or event outside the control of the Grantee, adversely af</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fects the level of achievement, or in any way prevents the satisfaction, of the applicable performance goal. </font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(d)</font><font style="font-weight:bold;margin-left:36pt;">Forfeiture.</font> Except as otherwise provided in Section 4 of this Agreement in the event of a Change in Control or the termination of the Grantee's employment with the Company as a result of the Grantee's death or Disability, if the Grantee's employment with the Company terminates for any reason before the General Awarded Date for a Tranche, the Grantee's interest in one hundred percent (100%) of the Performance Shares in the Tranche will be forfeited immediately upon the Grantee's termination of employment with the Company. In addition, except as otherwise provided in Section 4 of this Agreement, any Performance Shares in a Tranche that do not become Awarded Performance Shares on the General Awarded Date for the Tranche based on the Committee's determination of the level of achievement of the performance goal applicable to the Tranche will be forfeited immediately on such General Awarded Date and will not be eligible to become vested and nonforfeitable in accordance with Section 3 of this Agreement. </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">3.</font><font style="font-weight:bold;margin-left:36pt;">Employment Condition for Vesting of Awarded Performance Shares.</font> Except as otherwise provided in Section 4 of this Agreement in the event of the Grantee's attainment of age 64, a Change in Control, or the termination of the Grantee's employment with the Company as a result of death or Disability, the Grantee's interest in the Awarded Performance Shares will become fully vested and nonforfeitable on the fifth (5th) anniversary of the Date of Grant, provided that the Grantee has been continuously employed by the Company since the Date of Grant. Except as otherwise provided in Section 4 of this Agreement, if the Grantee's employment terminates for any reason before the fifth (5th) anniversary of the Date of Grant, the Grantee's interest in one hundred percent (100%) of the Awarded Performance Shares will be forfeited. For the avoidance of doubt, any reference in this Agreement to "employment with the Company" or "employed by the Company" will be deemed to include service as a non-Employee member of the Company's Board of Directors, and a Grantee's continuous employment with the Company will not be considered interrupted in the event of a change in the status of the Grantee from Employee to non-Employee Director, or from non-Employee Director to Employee, or from full-time Employee to part-time Employee.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"></font><font style="font-weight:bold;">4.</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Treatment of</font><font style="font-weight:bold;"> Performance Shares </font><font style="font-weight:bold;">upon</font><font style="font-weight:bold;"> Attainment of Age 64</font><font style="font-weight:bold;">, </font><font style="font-weight:bold;">Change in Control</font><font style="font-weight:bold;">, or </font><font style="font-weight:bold;">Termination of Employment as a Result of Death or Disability</font><font style="font-weight:bold;">.</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The purpose of this Section 4 is to provide special rules that may apply to the awarding or vesting, or both the awarding and vesting, of Performance Shares in the event of the Grantee's attainment of age 64, a </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in Control</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or the termination of the Grantee's employment with the Company as a result of the Grantee's death or disability. For the avoidance of doubt, a reference to the occurrence of an event "prior to the General Awarded Date" </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> mean that the event occurs before the Committee determines the level of achievement of the </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">applicable </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">performance goal </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in accordance with Section 2(c) of this Agreement, and therefore before any portion of the affected Performance Shares become Awarded Performance Shares in accordance with Section 2</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of this Agreement. Similarly, a reference to the occurrence of an event "on or after the General Awarded Date" </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> mean that the event occurs after the Committee determines the level of achievement of the applicable performance goal in accordance with Section 2(c) of this Agreement, and therefore after the applicable portion, if any, of the affected Performance Shares have become Awarded Performance Shares in accordance with Section 2</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of this Agreement.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(a)</font><font style="font-weight:bold;margin-left:36pt;">Attainment of Age 64. </font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(1)</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Attainment of Age 64 Prior to General Awarded Date - No Effect on Awarding of Performance Shares.</font> If the Grantee attains age 64 prior to the General Awarded Date, the determination of whether and to what extent the Performance Shares become Awarded Performance Shares will be determined in accordance with the provisions of Section 2 of this Agreement without regard to the Grantee's age. For the avoidance of doubt, no portion of the Performance Shares will become Awarded Performance Shares as a result of the Grantee's attainment of age 64.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(2)</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Effect of Attainment of Age 64 on the Vesting of Awarded Performance Shares.</font> If the Grantee attains age 64 before the fifth (5th) anniversary of the Date of Grant, this Section 4(a)(2) will govern the timing and the extent of the vesting and nonforfeitability of the Performance Shares, if any, that become Awarded Performance Shares in accordance with Section 2 of this Agreement. This Section 4(a)(2) will supersede the standard vesting provision contained in Section 3 of this Agreement only to the extent that it results in accelerated vesting of the Awarded Performance Shares, and it will not result in a delay of any vesting of any Awarded Performance Shares that otherwise would occur under the terms of the standard vesting provision contained in Section 3 of this Agreement. The application of the special vesting rules of this Section 4(a)(2) will depend upon whether the Grantee attains age 64 on or before the General Awarded Date, or attains age 64 after the General Awarded Date.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(A)</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Attainment of Age 64 on or before the General Awarded Date.</font>  If the Grantee attains age 64 on or before the General Awarded Date, a portion of the Performance Shares, if any, that become Awarded Performance Shares on the General Awarded Date will become vested and nonforfeitable on the later of the General Awarded Date or the first (1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup>) anniversary of the Date of Grant that follows the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">last day of the Performance Period</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">provided that the Grantee has been continuously employed by the Company since the Date of Grant</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The portion of the Awarded Performance Shares that become vested and nonforfeitable </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the later of the General Awarded Date or the first</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (1</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup></font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> anniversary of the Date of Grant that follows the last day of the Performance Period</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, whichever is applicable,</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be the number of Awarded Performance Shares multiplied by a fraction, the numerator of which </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> equal the number of </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">full </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">years</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> since </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Date of Grant</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and the denominator of which </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> equal five (5). An additional one-fifth (1/5) of the Awarded Performance Shares</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> become </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">vest</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ed and nonforfeitable</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> on </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">each subsequent </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">anniversary of the Date</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of Grant</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> until the </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fif</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">th</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (5th) anniversary of the Date of Grant</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, so long as Grantee continues to be employed by the Company.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(B)</font><font style="font-weight:bold;margin-left:36pt;">Attainment of Age 64 after the General Awarded Date.</font> If the Grantee attains age 64 after the General Awarded Date, a portion of the Performance Shares, if any, that become Awarded Performance Shares on the General Awarded Date will become vested and nonforfeitable on the first (1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup>) anniversary of the Date of Grant that coincides with or follows the Grantee's attainment of age 64, provided that the Grantee has been continuously employed by the Company since the Date of Grant. The portion of the Awarded Performance Shares that become vested and nonforfeitable on the first (1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup>) anniversary of the Date of Grant that coincides with or follows the Grantee's attainment of age 64 will be the number of Awarded Performance Shares multiplied by a fraction, the numerator of which will equal the number of full years since the Date of Grant, and the denominator of which will equal five (5). An additional one-fifth (1/5) of the Awarded Performance Shares will become vested and nonforfeitable on each subsequent anniversary of the Date of Grant until the fifth (5th) anniversary of the Date of Grant, so long as Grantee continues to be employed by the Company.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">(b)</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Change in Control.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(1)</font><font style="font-weight:bold;margin-left:36pt;">Prior to </font><font style="font-weight:bold;">General Awarded Date.</font> </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(A)</font><font style="font-weight:bold;margin-left:36pt;">Awarding of Performance Shares</font><font style="font-weight:bold;"> following Change in Control.</font> If a Change in Control occurs after the Date of Grant but prior to the General Awarded Date, a percentage of each of the Tranche 1 Performance Shares and the Tranche 2 Performance Shares will become Awarded Performance Shares, provided that the Grantee has been continuously employed by the Company since the Date of Grant. The percentage of the Performance Shares in each Tranche that become Awarded Performance Shares will be the greater of: </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;">1.</font>100% of the Performance Shares in the Tranche; or</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU7"></a><font style="margin-left:36pt;">2.</font>the percentage of the Performance Shares in the applicable Tranche determined in accordance with the schedule in Section 2(a) with respect to the Tranche 1 Performance Shares or Section 2(b) with respect to the Tranche 2 Performance Shares, based on the actual level of achievement (up to the maximum </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">level of achievement for each Tranche set forth in Section 2) </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the performance goal</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> applicable to the Tranche</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from the first day of the Performance Period to the date on which the </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in Control</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> occurs.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The applicable percentage of each Tranche will become Awarded Performance Shares on the date on which the Committee determines the level of achievement of the performance goal applicable to the Tranche (the "<font style="text-decoration:underline;">Change in Control Awarded Date</font>"). For the avoidance of doubt, the Committee's determinations of the achievement of the performance goals for the Tranche 1 Performance Shares and the Tranche 2 Performance Shares may occur on different dates, and therefore the Change in Control Awarded Dates applicable to the Tranches are not required to be identical. The Committee's determination will be based on the actual level of achievement of the applicable performance goal, in accordance with the provisions of the Plan and this Agreement, including, without limitation, the provisions of the Plan and this Agreement relating to adjustment for items that are unusual in nature or infrequently occurring, and the provisions of the Plan relating to the Committee&#8217;s authority and discretion to establish procedures for determination of the level of achievement. The Committee's determination will be final, binding, and conclusive on all persons, including but not limited to the Company and the Grantee. The Grantee will not be entitled to any claim or recourse if any action or inaction by the Company, or any other circumstance or event, including any circumstance or event outside the control of the Grantee, adversely affects the level of achievement, or in any way prevents the satisfaction, of the applicable performance goal.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(B)</font><font style="font-weight:bold;margin-left:36pt;">Vesting of Awarded Performance Shares following </font><font style="font-weight:bold;">Change in Control.</font> Unless the Grantee's employment with the Company terminates by reason of Termination After Change in Control (as defined below) after the Change in Control Awarded Date but prior to the fifth (5th) anniversary of the Date of Grant, the Grantee's interest in the Performance Shares that become Awarded Performance Shares in accordance with Section 4(b)(1)(A) above will become fully vested and nonforfeitable on the fifth (5th) anniversary of the Date of Grant, provided that the Grantee has been continuously employed by the Company since the Date of Grant. However, <font style="letter-spacing:-0.15pt;">if the Grantee&#8217;s employment with the Company terminates by reason of Termination After Change in Control (as defined below) but prior to the fifth (5th) anniversary of the Date of Grant, the Performance Shares that become Awarded Performance Shares in accordance with Section 4(b)(1)(A) above will become fully vested and nonforfeitable as of the date of such Termination After Change in Control. For purposes of this Section 4(b), the following definitions will apply: </font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;">1.</font><font style="letter-spacing:-0.15pt;"> &#8220;</font><font style="text-decoration:underline;letter-spacing:-0.15pt;">Termination After Change in Control</font><font style="letter-spacing:-0.15pt;">&#8221;</font><font style="font-weight:bold;letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.15pt;">will mean either of the following events occurring after a Change in Control:</font></p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;">a.termination by the Company of the Grantee&#8217;s employment with </font>the Company, within twelve (12) months following a Change in Control, for any reason other than Termination for Cause (as defined below); or</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU8"></a><font style="text-indent:7.69%;"></font><font style="margin-left:36pt;"></font><font style="margin-left:36pt;"></font><font style="margin-left:36pt;"></font><font style="margin-left:36pt;"></font><font style="margin-left:36pt;">b.</font><font style="margin-left:36pt;"></font><font style="letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">upon Grantee&#8217;s Constructive Termination (as defined below), the Grantee&#8217;s resignation from employment with the Company within twelve (12) months following the </font><font style="letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in Control</font><font style="letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding any provision herein to the contrary, Termination After Change in Control will not include any termination of the Grantee&#8217;s employment with the Company which: (i) is a Termination for Cause (as defined below); (ii) is a result of the Grantee&#8217;s death or Disability; (iii) is a result of the Grantee&#8217;s voluntary termination of employment with the Company other than upon Constructive Termination (as defined below); or (iv) occurs prior to the effectiveness of a Change in Control.</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;">2.</font> &#8220;<font style="text-decoration:underline;">Termination for Cause</font>&#8221; will mean termination by the Company of the Grantee&#8217;s employment with the Company for any of the following reasons: (i) theft, dishonesty, or falsification of any employment or Company records; (ii) improper use or disclosure of the Company&#8217;s confidential or proprietary information; (iii) the Grantee&#8217;s failure or inability to perform any reasonable assigned duties after written notice from the Company of, and a reasonable opportunity to cure, such continued failure or inability; (iv) any material breach by the Grantee of any employment agreement between the Grantee and Company, which breach is not cured pursuant to the terms of such agreement; or (v) the Grantee&#8217;s conviction of any criminal act which, in the Company&#8217;s discretion, impairs Grantee&#8217;s ability to perform his or her duties with the Company.&nbsp;&nbsp;Termination for Cause pursuant to the foregoing will be determined in the discretion of the Company.</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;font-weight:bold;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:normal;">3.</font><font style="font-weight:normal;margin-left:-36pt;"></font><font style="font-weight:normal;"> &#8220;</font><font style="text-decoration:underline;font-weight:normal;">Constructive Termination</font><font style="font-weight:normal;">&#8221; will mean any one or more of the following:</font></p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;">a.</font>without the Grantee&#8217;s express written consent, the assignment to the Grantee of any duties, or any limitation of the Grantee&#8217;s responsibilities, substantially inconsistent with the Grantee&#8217;s positions, duties, responsibilities and status with the Company immediately prior to the date of a Change in Control;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;">b.</font>without the Grantee&#8217;s express written consent, the relocation of the principal place of the Grantee&#8217;s employment to a location that is more than fifty (50) miles from the Grantee&#8217;s principal place of employment immediately prior to the date of a Change in Control, or the imposition of travel requirements substantially more demanding of the Grantee than such travel requirements existing immediately prior to the date of a Change in Control;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a><font style="margin-left:36pt;">c.</font>any failure by the Company to pay, or any material reduction by the Company of, (i) the Grantee&#8217;s base salary in effect immediately prior to the date of the Change in Control (unless comparable reductions are concurrently made for all other employees of the Company with responsibilities, organizational level and title comparable to the Grantee&#8217;s), or (ii) the Grantee&#8217;s bonus compensation, if any, in effect immediately prior to the date of the Change in Control (subject to applicable performance </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">requirements with respect to the actual amount of bonus compensation earned by the Grantee); or</font></p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;">d.</font>any failure by the Company to (i) continue to provide the Grantee with the opportunity to participate, on terms no less favorable than those in effect for the benefit of any employee group which customarily includes a person holding the employment position or a comparable position with the Company then held by the Grantee, in any benefit or compensation plans and programs, including, but not limited to, the Company&#8217;s life, disability, health, dental, medial, savings, profit sharing, stock purchase and retirement plans, if any, in which the Grantee was participating immediately prior to the date of the Change in Control, or their equivalent, or (ii) provide the Grantee with all other fringe benefits (or their equivalent) from time to time in effect for the benefit of any employee group which customarily includes a person holding the employment position or a comparable position with the Company then held by the Grantee.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(2)</font><font style="font-weight:bold;margin-left:36pt;">On or After Awarded Date.</font> <font style="letter-spacing:-0.15pt;">If the Grantee&#8217;s employment with the Company terminates by reason of Termination After Change in Control after the General Awarded Date,</font> but before the Grantee's interest in the Awarded Performance Shares becomes fully vested and nonforfeitable in accordance with Section 3 of this Agreement or is forfeited,<font style="letter-spacing:-0.15pt;"> the Awarded Performance Shares will become fully vested and nonforfeitable as of the date of such Termination After Change in Control. </font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">(c)</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Termination of Employment as a Result of Death or Disability.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;">(1) </font>Prior to General Awarded Date.<font style="font-weight:normal;"> If the Grantee's employment with the Company terminates as a result of the Grantee's death or Disability after the Date of Grant but prior to the General Awarded Date or forfeiture of the Grantee's interest in the Performance Shares, a portion of the Performance Shares will become vested and nonforfeitable on the date on which the Grantee's employment terminates. The portion of the Performance Shares that will become vested and nonforfeitable pursuant to this Section 4(c)(1) will be the number of Performance Shares that are granted in Section 1 of this Agreement multiplied by a fraction, the numerator of which will equal the number of full months of the Grantee's employment with the Company during the Performance Period, and the denominator of which will equal thirty-six (36).</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(2)</font><font style="font-weight:bold;margin-left:36pt;">On or After </font><font style="font-weight:bold;">General Awarded Date.</font> If the Grantee&#8217;s employment with the Company terminates as a result of Grantee&#8217;s death or disability after the General Awarded Date or the Change in Control Awarded Date, as applicable, but before the Grantee's interest in the Awarded Performance Shares becomes fully vested and nonforfeitable in accordance with Section 3 of this Agreement or is forfeited, the Awarded Performance Shares will become fully vested and nonforfeitable on the date on which the Grantee's employment with the Company terminates. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU10"></a><font style="font-weight:bold;">5.</font><font style="font-weight:bold;margin-left:36pt;">Adjustments in Number of Performance Shares.</font> If the shares of the Common Stock are changed into or exchanged for a different number or kind of shares of the Company or other securities of the Company by reason of merger, consolidation, </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recapitalization, reclassification, stock split, stock dividend or combination of shares, the number and kind of Performance Shares </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be equitably adjusted to reflect such changes</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in accordance with the Plan</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Any such adjustment made by the Company's Board of Directors or the Committee </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be final and binding upon the Grantee, the Company, their respective heirs, administrators, personal representatives, successors, assigns, and all other interested persons.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">6.</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Delivery of Vested Performance Shares; No Fractional Shares.</font> Subject to the provisions of Section 11 relating to tax withholding, the delivery to the Grantee of the Performance Shares that become fully vested and nonforfeitable under Section 3 or Section 4 of this Agreement will be, at the Company&#8217;s option, evidenced by a share certificate delivered to the Grantee, or other physical or electronic evidence of Common Stock ownership, including, without limitation, deposit of shares into a stock brokerage account maintained for the Grantee or credit to a book-entry account for the benefit of the Grantee maintained by the Company&#8217;s stock transfer agent or its designee.<font style="letter-spacing:-0.15pt;"> Notwithstanding any provision of this Agreement to the contrary, any fractional share that would otherwise result from the application of any provision of this Agreement will be rounded down to the nearest whole number, as determined by the Committee in its discretion.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">7.</font><font style="font-weight:bold;margin-left:36pt;">Dividend Rights.</font>&nbsp;&nbsp;If a cash dividend is declared on shares of the Common Stock after the General Awarded Date or Change in Control Awarded Date, whichever is applicable, but before the Grantee's interest in the Awarded Performance Shares becomes fully vested and nonforfeitable or is forfeited, the Company will pay the cash dividend directly to the Grantee with respect to the Awarded Performance Shares. If a stock dividend is declared after the General Awarded Date or Change in Control Awarded Date, whichever is applicable, but before the Grantee's interest in the Awarded Performance Shares becomes fully vested and nonforfeitable or is forfeited, the stock dividend will be treated as part of the grant of that portion of the related Awarded Performance Shares, and the Grantee's interest in such stock dividend will become vested and nonforfeitable, or will be forfeited, at the same time as the Awarded Performance Shares with respect to which the stock dividend was paid becomes vested and nonforfeitable or are forfeited. The disposition of each other form of dividend that may be declared after the General Awarded Date or Change in Control Awarded Date, whichever is applicable, but before the Grantee's interest in the Awarded Performance Shares becomes fully vested and nonforfeitable or is forfeited, will be made in accordance with such rules as the Committee may adopt with respect to such dividend.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">8.</font><font style="font-weight:bold;margin-left:36pt;">Voting Rights.</font>&nbsp;&nbsp;The Grantee will be allowed to exercise voting rights with respect to the Awarded Performance Shares after the General Awarded Date or Change in Control Awarded Date, whichever is applicable, even though the Grantee's interest in such Performance Shares has not yet become fully vested and nonforfeitable.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU11"></a><font style="font-weight:bold;">9.</font><font style="font-weight:bold;margin-left:36pt;">Administration.</font> The Committee will have the power to interpret this Agreement and to adopt such rules for the administration, interpretation, and application of the Agreement as are consistent with the Plan, and to interpret or revoke any such </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rules. </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All actions taken and all interpretations and determinations made by the Committee in good faith </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be final and binding upon the Grantee, the Company</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and all other interested persons.&nbsp;&nbsp;No member of the Committee </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be personally liable for any action, determination or interpretation made in good faith with respect to</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the Plan or</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> this Agreement or any similar agreement to which the Company is a party.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">10.</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Non-Transferability.</font> </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(a)</font><font style="font-weight:bold;margin-left:36pt;">In General.</font> Neither the Performance Shares nor any interest or right therein or part thereof will be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means, whether such disposition is voluntary or involuntary or by operation of law, by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy) and any attempted disposition thereof will be null and void and of no effect; provided, however, that this Section 10 will not prevent transfers by will or by the applicable laws of descent and distribution or by a beneficiary designation in accordance with this Section 10.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(b)</font><font style="font-weight:bold;margin-left:36pt;">Beneficiary Designations.</font> The Grantee may designate a beneficiary or beneficiaries to exercise any rights or receive any benefits with respect to the Performance Shares following the Grantee&#8217;s death. To be effective, such designation must be made in accordance with such procedures and in such written or electronic form as prescribed by the Company (or its designee) for such purpose. If the Grantee fails to designate a beneficiary, or if no designated beneficiary survives the Grantee&#8217;s death, the Grantee&#8217;s estate will be deemed the Grantee&#8217;s beneficiary. A beneficiary designation may be changed or revoked by the Grantee&#8217;s sole action, provided that the change or revocation is made in accordance with such procedures and in such written or electronic form as prescribed by the Company (or its designee) for such purpose. Unless otherwise provided in the beneficiary designation, each designation made by the Grantee will revoke all prior designations made by the Grantee.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">11.</font><font style="font-weight:bold;margin-left:36pt;">Withholding.</font> The Grantee will pay all applicable federal and state income and employment taxes that the Company is required to withhold at any time with respect to the Performance Shares. Such payment will be made in full by the deduction from the number of vested and nonforfeitable Performance Shares otherwise deliverable by Company upon vesting and nonforfeitability of any portion of the Performance Shares, the smallest number of whole shares which, when multiplied by the fair market value of a share of the Common Stock on the vesting date, is sufficient to satisfy the amount of such tax withholding requirement. Grantee's entry into this Agreement will confirm Grantee&#8217;s instruction and authorization to the Company to satisfy withholding obligations with respect to the Performance Shares in this manner.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU12"></a><font style="font-weight:bold;">12.</font><font style="font-weight:bold;margin-left:36pt;">Notices.</font> Any notice to be given under the terms of this Agreement to the Company will be addressed to the Company in care of its Secretary and any notice to be given to the Grantee will be addressed to the address on file for the Grantee with the Company&#8217;s Payroll Department. By a notice given pursuant to this Section 12, either party may hereafter designate a different address for notices to be given to such party.&nbsp;&nbsp;Any </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">notice required to be given to the Grantee </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, if the Grantee is then deceased, be given to the Grantee's personal representative if such representative has previously informed the Company of such representative&#8217;s status and address by written notice under this Section</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 12</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Any notice </font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> have been deemed duly given when enclosed in a properly sealed envelope addressed as aforesaid, deposited (with postage prepaid) in a United States postal receptacle.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">13.</font><font style="font-weight:bold;margin-left:36pt;">Titles.</font> Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">14.</font><font style="font-weight:bold;margin-left:36pt;">Disposition.</font> Upon receipt of any of the Performance Shares as a result of the satisfaction of all conditions to the grant of the Performance Shares, the Grantee will, if requested by the Company in order to assure compliance with applicable law, hold such Performance Shares for investment and not with the view toward resale or distribution to the public and, if so requested by the Company, will deliver to the Company a written statement signed by the Grantee and satisfactory to the Company to that effect. In such instance, the Grantee will give prompt notice to the Company of any disposition or other transfer of any Performance Shares acquired under this Agreement. Such notice will specify the date of such disposition or other transfer and the amount realized, in cash, other property, assumption of indebtedness or other consideration, by the Grantee in such disposition or other transfer.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">15.</font><font style="font-weight:bold;margin-left:36pt;">Counterparts.</font> This Agreement may be executed in two or more counterparts, each of which will be deemed an original and all of which together will constitute one agreement.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">16.</font><font style="font-weight:bold;margin-left:36pt;">Severability.</font> If any provision, or any part thereof, of this Agreement should be held by any court to be illegal, invalid or unenforceable, either in whole or in part, such illegality, invalidity or unenforceability will not affect the legality, validity or enforceability of the remaining provisions, or any part thereof, all of which will remain in full and effect.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">17.</font><font style="font-weight:bold;margin-left:36pt;">Entire Agreement; Amendments.</font> This Agreement (including any documents or instruments referred to herein) constitutes the entire agreement regarding the Performance Shares among the parties and supersedes all prior agreements, and understandings, both written and oral, among the parties with respect to the subject matter hereof. The Committee may amend this Agreement, provided that if the Committee determines, in its discretion, that an amendment of this Agreement is likely to materially impair the rights of the Grantee, such amendment will not be implemented without the consent of the Grantee, except to the extent that such amendment is required for compliance with applicable law, stock market or exchange rules and regulations, or accounting or tax rules and regulations.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">18.</font><font style="font-weight:bold;margin-left:36pt;">Governing Law.</font> This Agreement will be governed by and construed and enforced in accordance with the laws of the State of Florida, without regard to choice of law principles.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU13"></a><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, this Agreement has been executed and delivered by the parties as of the date first written above.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BROWN &amp; BROWN, INC.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: _______________________________</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; R. Andrew Watts</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <font style="margin-left:36pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font>Executive Vice President, Treasurer &amp; <font style="margin-left:36pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font>Chief Financial Officer</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GRANTEE</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;_______________________________</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <font style="margin-left:36pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font>&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>bro-ex102_7.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
bro-ex102_7.htm
</title>
</head>
<!-- NG Converter v5.0.2.38 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.2</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">BROWN &amp; BROWN, INC.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">RESTRICTED STOCK AWARD AGREEMENT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">(Key Corporate Leaders / Profit Center Leaders / Other Leaders)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">This Restricted Stock Award Agreement (this &#8220;Agreement&#8221;) is entered into as of ____________, 20__ (the &#8220;Date of Grant&#8221;), between Brown &amp; Brown, Inc., a Florida corporation (together with its subsidiaries, the &#8220;Company&#8221;) and _________ (the &#8220;Grantee&#8221;), pursuant to the terms and conditions of the Brown &amp; Brown, Inc. 2019 Stock Incentive Plan, as amended (the &#8220;Plan&#8221;). Any term capitalized but not defined in this Agreement will have the meaning set forth in the Plan.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Plan provides to the Compensation Committee of the Board of Directors of the Company (the "Committee") the discretion and authority to grant Awards of shares of the common stock of the Company, par value $.10 per share (the &#8220;Common Stock&#8221;), contingent on transferability restrictions, vesting conditions, and additional terms and conditions provided by the Committee. The Plan identifies such an Award as a Restricted Stock Award. Pursuant to the terms of the Plan, the Committee desires to grant a Restricted Stock Award with time-based vesting conditions to the Grantee effective as of the Date of Grant. The Grantee desires to accept the Restricted Stock Award and agrees to be bound by the terms and conditions of the Plan and this Restricted Stock Award Agreement. Accordingly, the Company and the Grantee hereby agree to the restrictions, terms, and conditions set forth below.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <font style="margin-left:36pt;"></font><font style="font-weight:bold;">1.</font><font style="font-weight:bold;margin-left:36pt;">Grant</font><font style="font-weight:bold;"> of Restricted Shares.</font> The Company grants to the Grantee _____________ (________) shares of Common Stock (the &#8220;Restricted Shares&#8221;).</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <font style="margin-left:36pt;"></font><font style="font-weight:bold;">2.</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Vesting of Restricted Shares.</font> Except as otherwise provided in Section 3 of this Agreement in the event of a Change in Control or the termination of the Grantee's employment with the Company as a result of death or Disability, the Grantee's interest in the Restricted Shares will become fully vested and nonforfeitable on the fifth (5th) anniversary of the Date of Grant, provided that the Grantee has been continuously employed by the Company since the Date of Grant. Except as otherwise provided in Section 3 of this Agreement, if the Grantee's employment terminates for any reason before the fifth (5th) anniversary of the Date of Grant, the Grantee's interest in the Restricted Shares will be forfeited. For the avoidance of doubt, any reference in this Agreement to "employment with the Company" or "employed by the Company" will be deemed to include service as a non-Employee member of the Company's Board of Directors, and a Grantee's continuous employment with the Company will not be considered interrupted in the event of a change in the status of the Grantee from Employee to non-Employee Director, or from non-Employee Director to Employee, or from full-time Employee to part-time Employee.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"></font><font style="font-weight:bold;">3</font><font style="font-weight:bold;">.</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Treatment of</font><font style="font-weight:bold;"> </font><font style="font-weight:bold;">Restricted Shares</font><font style="font-weight:bold;"> </font><font style="font-weight:bold;">upon</font><font style="font-weight:bold;"> </font><font style="font-weight:bold;">Change </font><font style="font-weight:bold;">i</font><font style="font-weight:bold;">n</font><font style="font-weight:bold;"> Control, or </font><font style="font-weight:bold;">Termination of Employment as a Result of Death or Disability</font><font style="font-weight:bold;">.</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">(a)</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Change in Control.</font> If the Grantee's employment with the Company <font style="letter-spacing:-0.15pt;">terminates by reason of Termination After Change in Control (as defined below) after the Date of Grant, but before the Grantee's interest in the Restricted Shares becomes fully vested and nonforfeitable in accordance with Section 2 of this Agreement, the Restricted Shares will become fully vested and nonforfeitable as of the date of such Termination After Change in Control. For purposes of this Section 3(a), the following definitions will apply: </font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font>(1)<font style="margin-left:36pt;"></font><font style="letter-spacing:-0.15pt;">&#8220;Termination After Change in Control&#8221;</font><font style="font-weight:bold;letter-spacing:-0.15pt;"> </font><font style="letter-spacing:-0.15pt;">will mean either of the following events occurring after a Change in Control:</font></p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;"></font>(A)<font style="margin-left:-36pt;">termination by the Company of the Grantee&#8217;s employment with </font>the Company, within twelve (12) months following a Change in Control, for any reason other than Termination for Cause (as defined below); or</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;"></font>(B)<font style="margin-left:-36pt;">upon Grantee&#8217;s Constructive Termination (as defined below), the Grantee&#8217;s resignation from employment with the Company within twelve (12) months following the </font>Change in Control.</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding any provision herein to the contrary, Termination After Change in Control will not include any termination of the Grantee&#8217;s employment with the Company which: (i) is a Termination for Cause (as defined below); (ii) is a result of the Grantee&#8217;s death or Disability; (iii) is a result of the Grantee&#8217;s voluntary termination of employment with the Company other than upon Constructive Termination (as defined below); or (iv) occurs prior to the effectiveness of a Change in Control.</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;"></font>(2)<font style="margin-left:-36pt;">&#8220;Termination for Cause&#8221; </font>will mean termination by the Company of the Grantee&#8217;s employment with the Company for any of the following reasons: (i) theft, dishonesty, or falsification of any employment or Company records; (ii) improper use or disclosure of the Company&#8217;s confidential or proprietary information; (iii) the Grantee&#8217;s failure or inability to perform any reasonable assigned duties after written notice from the Company of, and a reasonable opportunity to cure, such continued failure or inability; (iv) any material breach by the Grantee of any employment agreement between the Grantee and Company, which breach is not cured pursuant to the terms of such agreement; or (v) the Grantee&#8217;s conviction of any criminal act which, in the Company&#8217;s discretion, impairs Grantee&#8217;s ability to perform his or her duties with the Company.&nbsp;&nbsp;Termination for Cause pursuant to the foregoing will be determined in the discretion of the Company.</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;font-weight:bold;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:normal;">(3)</font><font style="margin-left:-36pt;"></font><font style="font-weight:normal;">&#8220;Constructive Termination&#8221; will mean any one or more of the following:</font></p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="margin-left:36pt;"></font>(A)<font style="margin-left:-36pt;">without the Grantee&#8217;s express written consent, the assignment to the Grantee of any duties, or any limitation of the Grantee&#8217;s responsibilities, </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">substantially inconsistent with the Grantee&#8217;s positions, duties, responsibilities and status with the Company immediately prior to the date of a </font><font style="letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in</font><font style="letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Control;</font></p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;"></font>(B)<font style="margin-left:-36pt;">without the Grantee&#8217;s express written consent, the relocation of the principal place of the Grantee&#8217;s employment to a location that is more than fifty (50) miles from the Grantee&#8217;s principal place of employment immediately prior to the date of a </font>Change in Control, or the imposition of travel requirements substantially more demanding of the Grantee than such travel requirements existing immediately prior to the date of a Change in Control;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:-7.69%;"><font style="margin-left:36pt;"></font>(C)<font style="margin-left:-36pt;">any failure by the Company to pay, or any material</font> reduction by the Company of, (i) the Grantee&#8217;s base salary in effect immediately prior to the date of the Change in Control (unless comparable reductions are concurrently made for all other employees of the Company with responsibilities, organizational level and title comparable to the Grantee&#8217;s), or (ii) the Grantee&#8217;s bonus compensation, if any, in effect immediately prior to the date of the Change in Control (subject to applicable performance requirements with respect to the actual amount of bonus compensation earned by the Grantee); or</p>
<p style="text-align:justify;line-height:14pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;letter-spacing:-0.15pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font>(D)<font style="margin-left:36pt;"></font>any failure by the Company to (i) continue to provide the Grantee with the opportunity to participate, on terms no less favorable than those in effect for the benefit of any employee group which customarily includes a person holding the employment position or a comparable position with the Company then held by the Grantee, in any benefit or compensation plans and programs, including, but not limited to, the Company&#8217;s life, disability, health, dental, medial, savings, profit sharing, stock purchase and retirement plans, if any, in which the Grantee was participating immediately prior to the date of the Change in Control, or their equivalent, or (ii) provide the Grantee with all other fringe benefits (or their equivalent) from time to time in effect for the benefit of any employee group which customarily includes a person holding the employment position or a comparable position with the Company then held by the Grantee.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">(b)</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Termination of Employment as a Result of Death or Disability. </font>If the Grantee&#8217;s employment with the Company terminates as a result of Grantee&#8217;s death or disability before the Grantee's interest in the Restricted Shares becomes fully vested and nonforfeitable in accordance with Section 2 of this Agreement or is forfeited, the Restricted Shares will become vested and nonforfeitable on the date on which the Grantee's employment with the Company terminates. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><font style="font-weight:bold;">4.</font><font style="font-weight:bold;margin-left:36pt;">Adjustments in Number of </font><font style="font-weight:bold;">Restricted Shares.</font> If the shares of the Common Stock are changed into or exchanged for a different number or kind of shares of the Company or other securities of the Company by reason of merger, consolidation, recapitalization, reclassification, stock split, stock dividend or combination of shares, the number and kind of Restricted Shares will be equitably adjusted to reflect such changes in accordance with the Plan.&nbsp;&nbsp;Any such adjustment made by the Company's Board of Directors or the Committee will be final and binding upon the Grantee, the Company, their </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">respective heirs, administrators, personal representatives, successors, assigns, and all other interested persons.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">5.</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Delivery of Vested Restricted Shares; No Fractional Shares.</font> Subject to the provisions of Section 10 relating to tax withholding, the delivery to the Grantee of the Restricted Shares that become fully vested and nonforfeitable under Section 2 or Section 3 of this Agreement will be, at the Company&#8217;s option, evidenced by a share certificate delivered to the Grantee, or other physical or electronic evidence of Common Stock ownership, including, without limitation, deposit of shares into a stock brokerage account maintained for the Grantee or credit to a book-entry account for the benefit of the Grantee maintained by the Company&#8217;s stock transfer agent or its designee.<font style="letter-spacing:-0.15pt;"> Notwithstanding any provision of this Agreement to the contrary, any fractional share that would otherwise result from the application of any provision of this Agreement will be rounded down to the nearest whole number, as determined by the Committee in its discretion.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">6.</font><font style="font-weight:bold;margin-left:36pt;">Dividend Rights.</font>&nbsp;&nbsp;If a cash dividend is declared on shares of the Common Stock after the Date of Grant, but before the Grantee's interest in the Restricted Shares becomes fully vested and nonforfeitable or is forfeited, the Company will pay the cash dividend directly to the Grantee with respect to the Restricted Shares.&nbsp;&nbsp;If a stock dividend is declared after the Date of Grant, but before the Grantee's interest in the Restricted Shares becomes fully vested and nonforfeitable or is forfeited, the stock dividend will be treated as part of the grant of that portion of the related Restricted Shares, and the Grantee's interest in such stock dividend will become vested and nonforfeitable, or will be forfeited, at the same time as the Restricted Shares with respect to which the stock dividend was paid becomes vested and nonforfeitable or are forfeited. The disposition of each other form of dividend that may be declared after the Date of Grant, but before the Grantee's interest in the Restricted Shares becomes fully vested and nonforfeitable or is forfeited, will be made in accordance with such rules as the Committee may adopt with respect to such dividend.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">7.</font><font style="font-weight:bold;margin-left:36pt;">Voting Rights.</font>&nbsp;&nbsp;The Grantee will be allowed to exercise voting rights with respect to the Restricted Shares after the Date of Grant even though the Grantee's interest in such Restricted Shares has not yet become fully vested and nonforfeitable.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">8.</font><font style="font-weight:bold;margin-left:36pt;">Administration.</font> The Committee will have the power to interpret this Agreement and to adopt such rules for the administration, interpretation, and application of the Agreement as are consistent with the Plan, and to interpret or revoke any such rules. All actions taken and all interpretations and determinations made by the Committee in good faith will be final and binding upon the Grantee, the Company, and all other interested persons.&nbsp;&nbsp;No member of the Committee will be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Agreement or any similar agreement to which the Company is a party.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"></font><font style="font-weight:bold;">9</font><font style="font-weight:bold;">.</font><font style="font-weight:bold;margin-left:36pt;"></font><font style="font-weight:bold;">Non-Transferability</font><font style="font-weight:bold;">.</font><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(a)</font><font style="font-weight:bold;margin-left:36pt;">In General.</font> Neither the Restricted Shares nor any interest or right therein or part thereof will be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means, whether such disposition is voluntary or involuntary or by operation of law, by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy) and any attempted disposition thereof will be null and void and of no effect; provided, however, that this Section 9 will not prevent transfers by will or by the applicable laws of descent and distribution or by a beneficiary designation in accordance with this Section 9.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="margin-left:36pt;"></font><font style="font-weight:bold;">(b)</font><font style="font-weight:bold;margin-left:36pt;">Beneficiary Designations.</font> The Grantee may designate a beneficiary or beneficiaries to exercise any rights or receive any benefits with respect to the Restricted Shares following the Grantee&#8217;s death. To be effective, such designation must be made in accordance with such procedures and in such written or electronic form as prescribed by the Company (or its designee) for such purpose. If the Grantee fails to designate a beneficiary, or if no designated beneficiary survives the Grantee&#8217;s death, the Grantee&#8217;s estate will be deemed the Grantee&#8217;s beneficiary. A beneficiary designation may be changed or revoked by the Grantee&#8217;s sole action, provided that the change or revocation is made in accordance with such procedures and in such written or electronic form as prescribed by the Company (or its designee) for such purpose. Unless otherwise provided in the beneficiary designation, each designation made by the Grantee will revoke all prior designations made by the Grantee.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">10.</font><font style="font-weight:bold;margin-left:36pt;">Withholding.</font> The Grantee will pay all applicable federal and state income and employment taxes that the Company is required to withhold at any time with respect to the Restricted Shares. Such payment will be made in full by the deduction from the number of vested and nonforfeitable Restricted Shares otherwise deliverable by Company upon vesting and nonforfeitability of any portion of the Restricted Shares, the smallest number of whole shares which, when multiplied by the fair market value of a share of the Common Stock on the vesting date, is sufficient to satisfy the amount of such tax withholding requirement. Grantee's entry into this Agreement will confirm Grantee&#8217;s instruction and authorization to the Company to satisfy withholding obligations with respect to the Restricted Shares in this manner.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">11.</font><font style="font-weight:bold;margin-left:36pt;">Notices.</font> Any notice to be given under the terms of this Agreement to the Company will be addressed to the Company in care of its Secretary and any notice to be given to the Grantee will be addressed to the address on file for the Grantee with the Company&#8217;s Payroll Department. By a notice given pursuant to this Section 11, either party may hereafter designate a different address for notices to be given to such party.&nbsp;&nbsp;Any notice required to be given to the Grantee will, if the Grantee is then deceased, be given to the Grantee's personal representative if such representative has previously informed the Company of such representative&#8217;s status and address by written notice under this Section 11.&nbsp;&nbsp;Any notice will have been deemed duly given when enclosed in a properly sealed envelope addressed as aforesaid, deposited (with postage prepaid) in a United States postal receptacle.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">12.</font><font style="font-weight:bold;margin-left:36pt;">Titles.</font> Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">13.</font><font style="font-weight:bold;margin-left:36pt;">Disposition.</font> Upon receipt of any of the Restricted Shares as a result of the satisfaction of all conditions to the grant of the Restricted Shares, the Grantee will, if requested by the Company in order to assure compliance with applicable law, hold such Restricted Shares for investment and not with the view toward resale or distribution to the public and, if so requested by the Company, will deliver to the Company a written statement signed by the Grantee and satisfactory to the Company to that effect. In such instance, the Grantee will give prompt notice to the Company of any disposition or other transfer of any Restricted Shares acquired under this Agreement. Such notice will specify the date of such disposition or other transfer and the amount realized, in cash, other property, assumption of indebtedness or other consideration, by the Grantee in such disposition or other transfer.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">14.</font><font style="font-weight:bold;margin-left:36pt;">Counterparts.</font> This Agreement may be executed in two or more counterparts, each of which will be deemed an original and all of which together will constitute one agreement.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">15.</font><font style="font-weight:bold;margin-left:36pt;">Severability.</font> If any provision, or any part thereof, of this Agreement should be held by any court to be illegal, invalid or unenforceable, either in whole or in part, such illegality, invalidity or unenforceability will not affect the legality, validity or enforceability of the remaining provisions, or any part thereof, all of which will remain in full and effect.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">16.</font><font style="font-weight:bold;margin-left:36pt;">Entire Agreement; Amendments.</font> This Agreement (including any documents or instruments referred to herein) constitutes the entire agreement regarding the Restricted Shares among the parties and supersedes all prior agreements, and understandings, both written and oral, among the parties with respect to the subject matter hereof. The Committee may amend this Agreement, provided that if the Committee determines, in its discretion, that an amendment of this Agreement is likely to materially impair the rights of the Grantee, such amendment will not be implemented without the consent of the Grantee, except to the extent that such amendment is required for compliance with applicable law, stock market or exchange rules and regulations, or accounting or tax rules and regulations.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;"><font style="font-weight:bold;">17.</font><font style="font-weight:bold;margin-left:36pt;">Governing Law.</font> This Agreement will be governed by and construed and enforced in accordance with the laws of the State of Florida, without regard to choice of law principles.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a><font style="font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, this Agreement has been executed and delivered by the parties as of the date first written above.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BROWN &amp; BROWN, INC.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: _______________________________</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; R. Andrew Watts</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <font style="margin-left:36pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font>Executive Vice President, Treasurer &amp; <font style="margin-left:36pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font>Chief Financial Officer</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GRANTEE</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;_______________________________</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Helvetica;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>bro-20200221.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-02-24T19:21:07.1424831+00:00 -->
<!-- Version            : 5.0.1.321 -->
<!-- Package ID         : 63bf4c34220d45a2b87f6e841022accc -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:bro="http://www.bbinsurance.com/20200221" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bbinsurance.com/20200221" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" namespace="http://xbrl.sec.gov/country/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2019-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2019-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" namespace="http://xbrl.sec.gov/invest/2013-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" namespace="http://fasb.org/srt/2019-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd" namespace="http://fasb.org/srt-roles/2019-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" namespace="http://fasb.org/srt-types/2019-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" namespace="http://fasb.org/us-gaap/2019-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" namespace="http://fasb.org/us-roles/2019-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" namespace="http://fasb.org/us-types/2019-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.bbinsurance.com/20200221/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bro-20200221_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bro-20200221_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="bro_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>bro-20200221_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-02-24T19:21:07.1424831+00:00 -->
<!-- Version            : 5.0.1.321 -->
<!-- Package ID         : 63bf4c34220d45a2b87f6e841022accc -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="bro-20200221.xsd#bro_DocumentAndEntityInformationAbstract" xlink:type="locator" xlink:label="bro_DocumentAndEntityInformationAbstract" />
    <link:label xml:lang="en-US" xlink:label="bro_DocumentAndEntityInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Document and entity information.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="bro_DocumentAndEntityInformationAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="bro_DocumentAndEntityInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of each class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>bro-20200221_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-02-24T19:21:07.1424831+00:00 -->
<!-- Version            : 5.0.1.321 -->
<!-- Package ID         : 63bf4c34220d45a2b87f6e841022accc -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bbinsurance.com/20200221/role/TemplateLink" xlink:href="bro-20200221.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="bro-20200221.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="bro-20200221.xsd#bro_DocumentAndEntityInformationAbstract" xlink:type="locator" xlink:label="bro_DocumentAndEntityInformationAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_CityAreaCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_LocalPhoneNumber" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_WrittenCommunications" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_SolicitingMaterial" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_Security12bTitle" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_TradingSymbol" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="bro_DocumentAndEntityInformationAbstract" xlink:to="dei_SecurityExchangeName" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6630642176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 21, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bro_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 21,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BROWN&#160;& BROWN, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000079282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-13619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-0864469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">220 South Ridgewood Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Daytona Beach<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">32114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">252-9601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of each class</a></td>
<td class="text">Common Stock, $0.10 Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BRO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bro_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and entity information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bro_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bro_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>8
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bro-8k_20200221.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "bro-8k_20200221.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bro-20200221_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bro-20200221_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bro-20200221.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "bro",
   "nsuri": "http://www.bbinsurance.com/20200221",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "bro-8k_20200221.htm",
      "contextRef": "C_0000079282_20200221_20200221",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document And Entity Information",
     "role": "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "bro-8k_20200221.htm",
      "contextRef": "C_0000079282_20200221_20200221",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "bro_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Document and entity information.",
        "label": "Document And Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.bbinsurance.com/20200221",
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of each class"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>bro-8k_20200221_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bro-20200221.xsd" xlink:type="simple"/>
    <context id="C_0000079282_20200221_20200221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000079282</identifier>
        </entity>
        <period>
            <startDate>2020-02-21</startDate>
            <endDate>2020-02-21</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0000079282_20200221_20200221" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0000079282_20200221_20200221" id="F_000004">0000079282</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0000079282_20200221_20200221" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0000079282_20200221_20200221" id="F_000002">2020-02-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0000079282_20200221_20200221" id="F_000003">BROWN&#160;&amp; BROWN, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0000079282_20200221_20200221" id="F_000007">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0000079282_20200221_20200221" id="F_000006">001-13619</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0000079282_20200221_20200221" id="F_000008">59-0864469</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0000079282_20200221_20200221" id="F_000009">220 South Ridgewood Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_0000079282_20200221_20200221" id="F_000010">Daytona Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0000079282_20200221_20200221" id="F_000011">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0000079282_20200221_20200221" id="F_000012">32114</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0000079282_20200221_20200221" id="F_000013">386</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0000079282_20200221_20200221" id="F_000014">252-9601</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0000079282_20200221_20200221" id="F_000015">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0000079282_20200221_20200221" id="F_000016">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0000079282_20200221_20200221" id="F_000017">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0000079282_20200221_20200221" id="F_000018">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0000079282_20200221_20200221" id="F_000019">Common Stock, $0.10 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0000079282_20200221_20200221" id="F_000020">BRO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0000079282_20200221_20200221" id="F_000021">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0000079282_20200221_20200221" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>10
<FILENAME>0001564590-20-006078-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-20-006078-xbrl.zip
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MP@)2&D.^\E&9!;9-(=,4)XW$SMZXE5?J-Y*26SC^W:"+_P%02P,$%     @
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MC"+2Q&**-)EB\H:%3EIK1\,,P"S$JG'7DA%_OY&C&KYQA+RN^*Y;K0 %-33
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M&I S)Q5NX.':3#H64AT*@&4.80T9I(SWRX:(9* GC$NN#,<,-Z;@I=HI&P'
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M;7K,-DQO%'=>=!'WAY&%$]Q,/(6M!HQ9/'\9RUBKQ1HX 4:$51I&!Z5B=BU
M\Z@[3)0GH%&01(-['BRK=FF?M( APK\2A3+4ZL\P5\&<TN8V;C"V LDPL82L
MS>Y04M*M%&9] !O@F@$?Z@Z407Y+XD3A4(#38JH3:2[SX'%;LK\3Z&0$^C+
M:#@(W%8I[=V8-;740S99HW8C(P:+TZ,P#SQX\\0W,=2WW^T#T30K8]O(C[>2
M]@J/NTVGU].R^ /)/==QOJ<<\'+$?]KVJI?NA_'"=O([A.:YJGB56>G*7&TC
ME1Y"8 8H=O'.0E3-?9=I26,;C.M(@ZW&V!YHYN%G"82\IC$/< ,8WG^7[4K3
M0 2F5=I<R=@;4WW%VXZPOO/(8I[YIBU8)TJ-A-L!!BF6 *R1--WC"OS38L9
MX=9)I: 9I.8(\Q) VM[.4[*C;@TU .*\&5+22\V-*<,9"_D/^V =Z]FCPZUR
M61\ ]P78+G3* N;CNYC>Y6:Z9*?:G-4Q*Z<3G3-KP\)\21@_CSO2F[XS$ &S
M8?J!VZ77VF>M?=;:YT?5/HIA#/))U$\&C"%#O\[X:CE@'/$'VX6N[<G'TZOC
MPR-B*40VTS!L]OJK>9V%8K..<E58%]ZBW@6X8= HRYXTO0.*1'C1)G0:U,^_
MJ/4,0M8#IY>G3W@G'<:)K>HP#HF-Z6*D5VG>-:!/@[\3GN[ 9E3&9=S_ NX.
MPARH"=0G8>JF"&TTB=$&RB%KV%[#]AJVU[#]"-C6'2[O06U_,=3&KR</UX_&
M@GH WLJ:QL-(7EKW%*O:'DX;*H)9P9H5M&,?W.1H2'C9,;MTCG+QM9"I0/(6
MZJ\6^!7V'%JWAWX,NDPP6[R;=%&/H3J#\I:+V#P10.M2CC/:S(AY&A8TB\F@
M]^_&&O?=1S>?MK!I][%BJK$_ODK'+D*62$?< JO+4GIGK&37 CW5'-$PN&>G
M!CK@;[];W,U^O!<[;-94,FH464MEV\WU['X)WDJ#\#/(9KS4%#J)2&;XT(-U
MB_%EY?&5XS+YV2_!Y./_Q>O&D&,WGSZV: S)>_GD*2O&HYDF%XU_]K)>+'&5
M<=7M+L]U:CM/;'C]T&?>]AS7<Y[3%LF-Z_DMD?N_#)P.]=/@T*GY6H4]IH20
ME6X(4/>9 *LN*-N.7UO;ZT]RY $_+_YF;/6,OY_5PEW.1%V-W+#/TIT]H&7;
MB8RYPAT_'09:G8-XK.\<++@+I^[L[KR;ZZ:;!?E]SBMIEG(<V+*)G:(SX4R1
M\4)ZN<[>;'*9+O3P _#ZF4CV)-&>PL'MN4ZU]J-QP[%Q1GO95ST?=!W=J!1-
MO5#JM?&#8?;7UNDQ)GXUD_$ AGN>(2Q'D^-AE1^%-]_2O!U0TI%X@51+BC*[
M\USOSQVGH[MCQKRI,61!^DGAACE\@5\8@BH^I7N^[S\1-<>1C8'=3N?ZBO6+
M2]<:K5].(M9@_' P]M>L]_KF;0*,_3]W'PC&]QW 66/Q6B >)A!KO"W V]J:
MNU[?M)W&")KDCX_-+X.C4@%NE"5XXL<NI,X\6_ADUPT_:;ARX8-+#[BQ>GT?
MY<B7=$X_GQU>_=8\N7S(34H3%^':KZ(N43 N<F?\[+6R?R=<#F\&G..29[L3
MHCEZ'VV81'T2T$29XXM<I=\MQF9:C"A@0+OO  ]=M5B'1NULTX^Q5M(,N"*0
MQ%#&5#>\3N!)[Y5^:9(?4\T:DY?,K="V G,!_O,NEVY/+'Y #A2H]QO5C7L^
M"K![OVZZYXO(3ZIB<YB:+C,_TFJ:]C6W%1[??4/RWMZ0UFRX_/$\ =NM^A#F
M8;.%QS#>L25JPX_-\V]GV;6G^+M$3L^.G#77ONHA/ O7KL%PS5:K/X9%V6II
M6U1620GT&PMR\FO8V/-4'+^473XKQ!V5RPK4W&)2DV\.^1*)_L,_1[G&\548
MPH(X[K\VCBW@UK<[V&E?02B1SRQF$J^8$TFL6/2VR8#G$RX9WAY%\=LSRUXN
M&/]6U4&E)<*^Z4A'=R/X\?]02P,$%     @ F8Q84)V6B3',+P  V-<!  \
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M\67V^DJ&^?35T>$A6LO^>HX?FM_A#6<QG\$>OIR<??CXQ^\\RR_0NY2*\!-
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MV-'A_M_9+H"9NA$%^$Y**77PE?B_0H((P=E*_,[8C"\1\':U#;F+D9AP:@F
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MIC]J=URJQXW-/:A-:8(T>!* (VQ:Q&&J(C;HFF*[Z+VR3:*;;7K7_VI#4@J
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MEEM2.KS9CT=QE>NK80]*N%![-K' ]H)N1ZZ!-TOTAV_Z%4@>*0D:%Z:*H$5
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M6WJ;@%Y&OB()I 'F5F854MN(T9N->8?!8U4@ ;2O.].ITK-*$+'2B4$%LG1
M'E.\\3,Z.D+02V66D_V- 3Z*/U$F%*8S8AP0'Z>TVB 0649/J31>W:VQC* 9
M$P!+0U1'O.]D'S\E<;:-*_CEUEIM1T/WG8BP2135A?U307Q5 KUFYPG[5;MZ
M *5JRO#G,G5+)<2ZC2*M-^FHVBJ2?R/>I^.C ^VST8M932EO<YIUM/RH;L*U
M.\L/SQN,4&U4 FGDC4'W9*ZDOR!)'QB/&(EW%N U=Z0AV%V5K2,M85MM?CY=
M9MC&E(P$E%UI$LO #HVKJQ@7R54,9#F5\XTM1$-!$67'HB!CA&L]990F7T6*
M77A1)A7$Y.$!3K5.)@INP0"Z#&Q#Z@SF49)\W8>32I?VY8:XN3N ,W95C-A#
M5:M2U(2*T<2X W+TC%"A7LW!O3XHUUY1O0KPE>)JRH IL5Y!5KEIDR(*%>RN
M9":,.\?F:6L_BUL,US:S<=>F">)HR$* KUE.+#@Y8ZZ 4HS"2+X<IRBM/$PM
M;T''H!.S56H]^[X7]OWCUNS[G3$@+O QRVO=@"C=3Q7P;%I:&Q+1 LR35#4Y
M;G-/;'0I;G(GDN<,VR52/?X].18;/85EFC1V].6*.*H'%9*N&JU(FJ9LQ_7+
M'*H[PFHFGPN$QWS,M6W;F!-=PQ4RG0YFL(\"3.H#S^OA,-(,X)VVN\IJC99K
M&R5;I7E%[<$TDL*V272Y0RWU,XX)8I@=QK/-;N@J\I2^Y?K"Z&QD:,^_]>11
MZMB%J6@B,':W.D=='J=RW[ L&OO&F[GHN+%3.]4Q/W*T-' D2[7!T"8L28M(
MA6&J,A//B(>@U:W D=XR!WK;Z7:]"&T7H3]M+4+_F9"QL5Z 7E88O\(<CB7-
M2E47WT0:H':W4 .E-- U1<3W)#7LXXGYT<6D'L%:X8P-"\.>R9A<O!1=+:@>
M]>\K!G;4+0;V\PUB8-9[Y%@+U:L5%(U,^4)Q]CG0":7O$++-P<ZHFS4DL1/-
M5!W6:ZQ$7IET4 ZD/Y-/JFI)$;&5$]@ZNI6Z<'2G#LP*RA72=0L+L'G))J,U
M/9)8V-%A'PQ[S S$BV 8DN_0'V_^213IVU) F>-?16S=V%56HDIL:G<FU:(9
MI>=DDB34IJELA7S_.WWH<0MOUC[P9B6;0RZNKGJ>L)DPB2E]<*T;DIH86(3]
M9\AB-%WP3-9J[9JIM,8XK"'I\(2:_N_/AHW:XY38^K"H>F:?NH$%EL%3IWE=
MQ5UBF_%0(1U/OUO1P5-2(+8QOH\.OW?\\3R)]R]UN*=68-*BF?? OL=$;+YU
M(O:'V#A!+(S/]24E:^*[L688UJ&!!AS.@2]02V3L$8IN9OJ,B?[:D>/T$W&]
MI:CP:70#\S"2(K;&IJE<QD_S2(03=+'$03$;X2V48N#V/*M<P(<]\C+TTPB5
MFJG<A>6<TNU'3#*F\A&6A#U2K8T;\:L!?OFO(IRH:_4BL<!P9)[S8*J^F? 4
M+.?IZEHB,=%A9)T:)=3-B@)UM(SM.O<:\OAK6LSS8+FG5!$4BZ!0S.:H@[CK
MKQ]MC*4;^ I>5$K_@!_C1!=/O[;W= W8U%RHI6_L<DI5C@[+QM3ZHD +&2H]
MI5_5\3@A5=P0'! %M4*1!<;/$*(?08X*(\<I%J_"T('$@PZ=EO2-*5B5M?6N
M+C]YSVAKWO/6P85W)2YD%5]7F:A0(HRH(1(BE_V(^=>NJYAZ"RL_L;K94V"*
MEM,"HME_W'H)8E.M"56)#-DEW8)KVXOK9L,NJL\ 439&1)R[5Y&6C-/8-,"K
M)J6H'LK8>P[(#TAN]7Z]W5K"QAZIW6HF=3?;L%9#0XU&Z"37G+JZ6I2XC'TB
MK( E*](%YK>M/Z[FJRKP!MJ\]/^'J(^&C4\ZLPW9R5KFHF-M)M/?>ASK?1O*
MG!=,[# &R>H=AVH@,XYVA<K,.XCJJS;+I!B[%1WP6W-@ Q6^K!YAZ9JI!&B,
M[Q;C^E0]ZKR5-;W6\_$[-AB:K^_KPJ#_++,!&WFRS>;@4>5V]K$(*:QFNKH*
MZA0[4SULW(I<_LTD#-9L3/=2<9.3B/%_JO?"T'\WECUDGXD@^+*2U&7HE I>
M-7:&MCNA31DK*V/7Q[L;Q$1);CK-D!Z$:<S^R"VWT/?NUL=4Y84F0VU3B;).
M^P#<B% 5+U>L<M-TMI%N]'Z%[6JJY<+X-C!Z4)AY^E7D;,&C0G?U5+EU38E*
MVJEH=A!22%1B]]$Q,A/M.U"W2VM-T;8E4PU'JYFF;N?1H5OT1XF,E!S9E)U'
M]Q( FZPS;VF:;2?:^:PN._\W-S><5XH'RX6Z*TI&P NXN8.TDW9 +)6$0 SV
M5,_E;IG+=0[,'G<+S!X=;\T6S^D"BE)-Q<(,?2E%3MK?!.^5T<G-B"WV[H;F
M]-9*<APF/(0A=CM>O=@>4"S01(FB'VRC5%W#88S%AE6L9-.MF4-_@<0]EMHM
MNY*&UY0?_(DO4U",08-'HU_1\%LT]?1BU#+6]D<X.AZ86U')K4C*&EJW*DO#
M53[+VDRS6%RDFB:K;UII0N2H=)WV"*O'$EX^ZL/+CYD-^A!>UC3LJF/K.(LW
M 0ZO8E[4H=$])DGF<(R)GX)GZ)%;<Z"@ *TI&,,A5>Y.]>NI,A@7,BFRR-S-
MI"UGYYJJAE>=8@^Z@X'DB>:QZ/>KWKQD!%O)Q;TY;A GWJQE1>[HX_-F@5X1
MBLIB&PDB#7+XA 4@L:(,LEQ$C!>5*><%9^H6,W@B$SR"+T6\$!%\Y6@VF(N&
M6<\9EZ$MNX+O=TF7@4\Y5ED!'6#B]YX:]H^8'OF<4V,8>B8BI^$\YT$D^J#G
M_?@P-E_YM$Y9O\1&^XY+F3Y2CJ)UANFPU9@: P :Q5)5^,61UJSA88R)H%8I
MTH50_8)&/%.9[O4$!35,:8.NZ/V];7C'V//\!C5?-N9F4>@/=-]0'&%NVQ"O
M+X=MZ,^G' Z\O)A/.3-"J=/FDGIUSGK/CVO6D:J!FIIR5M7\Q127#55Z,,_H
MOD?L<1S)TDU=C><-J%'RVEQUA?CH [*)Q4@CUDQ<2$# /,&T>=P^C\QMDV5,
MT!0G%R.8%D>@'63)VDWH:A+M5JM;Q]SJ*>1SI&7I>R1KCFOR2QH@)&5QL^,4
M(J>DBN(,V0?MJT?/DHH[KYC4**>0H\SFN6.%US0OZI7GU@F98F-;7:L?:L*C
M0*O@CO95<A3EY]03TX+0726U^ZW2MK9] ::D2WOLP+"+@)+#@?(]9-.!*8\F
M\8M]S1&99G.#RTB:(X"<NE;7#$_IX*$P6>4U<)A02.O*>J9YQTQS^^Y=IX@Z
M(!%YFKNQW&K72A62$]]$4.@FE_E58J\S#)PA=#2JVC&RC M2=IV<V.17RM\T
MS^;)1&6 &(\Q "DOJ,^<*%/=>MRZ8]S:OH?&9[%8S4K[4*OGMW=/N6E(@P8'
M;#:EK@$C8;OXTR6Y29'FVM4!:(/I.\C_%@ ,"AX7L4#3&NQW5?,E=;:P#KJ0
M8*2I=?!?CT&W0.AA*,93&4G%?6S^#5>W'B";+%]V7ZV]:*MVL:$#1C#*EA]K
M3J-")SJ4BR_;P!@%ZY0$[.GC;NEC^R8%9S'>$%*B^&MV O\+J97B.E[L9*"1
MAI($A6J]2)B,AHSZF J0P]H+J&RF/8>EJC0/H>8OLXA3P-XT;&H/;!2;6:)_
MI*M*S&6@!3J_!%W<85,+[*BZ]IQ4(=-,!+X#P)<)%90$ER+IKL[0%-(SV8DS
MS+BC"ZR!3(:U>CNJ2)ZI(F[W#.M9(K)>$6!;@]!U,K56(#H9#Z_U-<!J8%82
M;Y7Y*E2'!'.K'OKYZ')N1?XZSZGB<M1<J!S:,ID1W2D9T? BM,UJ<M5R)1-Q
MO5W, /MEBKD],\!MBF/AZFN3N$'\L;YDI\W84/7X.@SM-.8TM>%T^\VDB'A>
M\C35XH;BM2D%E1N?[;G7'7.O[>O#WR<@W4E\_<ZOUK$KH_]-Z&'=Y E KITN
M.D]#R\=P77,_D[&*_R9O'W[X-0)5,N1EWR;%O1#=@VDB5=LG>-/<\JH\2UYC
MU\,*:1Y3Z+X/:]X52_$!Z-U3.YZM2^VXSTMPNOS]<,[^_'!Y?O;Y,_OSM[.+
MLX^_#NK2'8-W%/VP)K$JD#6-ZK3/Q.I(U3N)QC+%AF1&]1D!:WQLH0H?4/6Z
M<.__WN_?MQ<?_SQG?^&S^6M&_QZP#^>GOHOLGB3ZOX_B;X_B_=][^/MV^8I]
M:?^OQ\S^KZ=_V06V^@]3T!_^Y'F>/2%499MJ4M>]J$V=,S*=,!+_3_35?$H%
M1IW1.WN)]^\4J4BU,GC#B4ZG4HS9KS+F<2!YQ#YBX8M(GX!>V2_"2\KI__KS
M]_W%R?GEV=D3( $O%M'38?]WZ[]/PTS86MUQ_YJZA0?!6!Y6U.O9_46]WAR,
MDG")P:^#:3Z+X!__'U!+ P04    " "9C%A0_>0DC<,:  "^L0  #P   &)R
M;RUE>#$P,E\W+FAT;>T]:5,;29;?)V+^0PZ[TP,10H"//L#K" S834P/=F"Z
M'?O)D:I*2=DN5=5F94FH?_V^]_*HK$-"!AN$+7^042DKSW=?^>(?IV]/KO[W
MW1G[]>H_O[%WO[_Z[?R$;>WN[7UX>K*W=WIU:GYXUM\_8%>*IX74,DMYLK=W
M=K'%ML9:YX=[>[/9K#][VL_4:._J<F^L)\FSO23+"M&/=;SU\N]_>X'/Z'_!
M8_Q?2YT(^&.@LEUQ?;#_Y.-/?6@#O^RYGU[LN<;_V-UE%V_8299.A=)"L>GS
M_G[_2?_ISVQW%QL,LG@.___M1<X*/4_$_VQI<:UW>2)'Z:&2H[$^FG UDNGN
M(-,ZFQSNY_Z)SG+Z2F_(-!:I/MS_Y]$P2_7N3."[AX,LB<V#(9_(9'[XJTBF
M0LN(FZ>%_$L<'CR!3LQ7G,)AFJD)3TRW&G=N" _@:2I,JRE7DL-8S#;<>GEV
M/98#J=D!K.W%7OZR>SD13%"HQ[">5Y=O/URP'_@D/V+T=X^=7YSTO\[2[$JN
MY$04[$+,V&4VX6ES/5LO?T@'17[T+6SOY=G[J\OSDZNS4_;^ZNW)O]GQA^/+
M4W;\YO+L[#]G%U??PAJW_RWF@/<JSQ37@OT&!$&H@NVQ=RH; JJ<T$J"YV_U
MN/J^T]B"!P6L/\M"R^'\YEU??5?M6=C=NL-&A^O^J?_C+_^$]5R-9<$N1:&5
MC+2(V7N=19_8\8RKF!V/E! 3:,VV-3;[X;]^?O)D_\@_IN\'1SL,?J,3@O=E
MJC/&"Y8-V<?@7X\]V?_X$?L1KIM3/&IH]@9F[KOJL8'0,R%2]DIEL]21%?P;
MR$H:]7N,L]=)IF3,660A!E@5])R-!$'%3.HQD[I@13DH9"QA$T318\'()]DD
MY^G<3Y^G<379VAQI;D)4L\M+593PC,$JL1TL>E)0!U&6QL0U:>WXVX(5P$X<
M_&+W&;[#QLFI8.\2#K_#QG'8V1@V,IP&_NCFT&?'Z9S&91'/I0:P^PN:#TH-
MQZQ9+(8RI7-@=&;5&<YDDK QA[&PYXG@J4Q'K!": =C@EJ7T XZUA'BO#-]K
M@61MB'\ M$,D,_O*<I5-90R+M^"#D"C2PH P?)E(#>#F 2A#+(0OIU*)2&?*
M@Y:%8 ,D6_[%K1WZ-99%I 3UB9#)2ST&A-%S''6$$&WPFWHKQEP)WV\$/<%;
M!0%G?2R ?0XB&4]*P?Z[?[#/<L U>KL&JB>F!P+O"FT .31 &X(A_&@V32@^
MD E.2UGR@\C38U/XAI!9(53/+"..K53:C75V;P$5YF[>9E?ZS.^_1$B00R (
M0!VB,71A21TBW@(RV&?O.I'>;H]!W-J @(2%5.:4S7XOZML0*PWXL#O@!?S6
M7KP;U)(B)H9#@ 4D&=S/H49*S7)=\V J/(I$KNF%!;.A;4:"0>T'@@VR,O4;
MNHS6T>[B3WH5?@(T+ +B'<-*DWFO!M&FCVK^0-$%C$^S<EM1AQ>:5J\YKXJN
M#422S9H4[?&1K_T'HEWL!?[0V+=$#/7ATQ]IM2_VL,'+6K.6#+GU\J"_4L..
M 0@45AP%X3&$/J)N;F1"# =HA)@M[ IE%A %W%\[ 9T,*5R-]+7&]2S["P+?
MO9W[!H@[P.O)K8%XQ0'^L/1_*1B?71,A1_J/$N],%J+B?B#&O1=$&]E30YUK
M4J"5\L24>/$0.-/)F -GQA].H'>5)2Q3GM[+U,@FELQ;-/D7R/N3/,GF5K!$
M'A;2<&2F,.$RH2%BP:$!='HJ"\OR>XW>)&D/A9]>:^U&>AT($% $&Y9),B=6
M*0S/@J,'$!@*D(8'B2 1 SH9RB&,N_U<CU'$3X%EJH*K>2?3[%4;J,=<UUD0
MK&> *HF18LJL+&!XLP$U<8,67TB0Z;NX\AU.K<?DDOUWYP2[!+O <!)*\ *Z
M&@AX(&ZQ&;<\'69/08#0]-I"$9]FH*OAGB H9.5 ]^P400(4^+RMJ@!1WEH"
M8%L(3%L+#F#+3R;&WF+L#(XD*6,!0H&:RD@8  6@V3TS?: Z-!F /%L7>6'I
M;1'<"J/!]E1@L10K:%JHH@U0SDY!-74*LU"JS+53VFK(&7GDQ!\*S759-)"1
M#54V87XEL-S:RMS$>[AIU+3S9WS//:R:(J;MHGA:ZQ\4 5U_NI8*8] _-6O/
MX,L,B?9NY0;-^0AD><"_3[M\""=[R),9GQ=',QGK\>'!_CX:7;ZX!?M[M5Z]
M #3F$UC#Q^.S\[>__\8+?8GF$T"L=W 0K_ <Z)<GR(%Y!_M=@S6L)AD\7;'=
MUY90KF!/]<00J%6%\A7;M?C*%^Z_S+/T"W=IA:<56\L5VZT\2RNQ$<%>]?SJ
M4MU9Q;&<#<2*;:=ML>W.('C_<K^=R1JRI\=,=F\ @&V^\Y6I4$MI\<K1^>=H
M*K5A$J&!8>\6.8] !3O<W>\?/*<Y!0+VP,O6@"$A*ATCL^_0I;8!JYQ-GBQ1
M('Y3TPZI&VWX@<C^.0*XT8R*&U4CZ("3Z8TD<MH/IW<\Z=([[JZ,55;*V*Z6
M+*\K[)W1(?)2Y5GA3-0P.Z\G 929"0ZS!#86U6;::6L!I$GR/ =4^4IDH.U1
M^+XIP6)TWC[8N8T%9B%&6HO;"D!D;7 KD96%PW7RUH6M"?#0O\8 !\:55EF!
M*2EX -%15"J%#PQ)Z+#%'*X,N0F0F-VQ6<W!LTYUYP$XVN?/:L&V/C"\[WXN
MP!\O!OA=VS2TKS6,2'4-'V'XX*>C-BNS@]6\=/@#LHD9;A+;/GBRPR;0:%P$
M\-<!:+VF[8B,5&@,2VNT&EN=\+(0'9SM"*3%#: ^,D!]=3.@HM[4@D6 &Q +
M2N.*#"&D#1>]3F &00(.P$(5&IN6&\]NAFIL;U?5)1Y^+W#9F-7Z@.G6RXM,
MXT$6&N1$HD-PLF0"+Q (T-6+9YS94 0X.*Z HJTB9GOCJC/U<ALDT^W 6$A1
M:S WEM'XD&U+"G#BGT$&MZ5[I_*"=(W>X1FAEU=[>YHE9:K1B-]8Z+)%!62=
MT/HST!C).\QNNF,$%XRXD,9P3$9K%Y>0BJ)8X%GZCK!P?=#N3MSAR<W<H4,6
M]]AAI6]'EBO)^.ZR3_B*$UU:@K:190J#Q/#3$%3:6!9CV*P"O9#HY^!)(8=P
M"@Y[L*-@,%R*'48)U)P+A]\3(%T8!(54 %IAU%62%:42#3>27P*0M*&)0.+D
M9,7WE12$PA*5Y@E-PI& KET8<IG0" K></%3Z)(1"M\/!#BK?"./!0R.2XU!
M3T;/F"D,4TJ17J(WC)AO_02<DROH*LOS3.DRM0," 1 ]H\I;_Q>,TC6[(T,R
ML%]8GE"X=O2/P(OVX)T?J[WWW'L$751HV!ZG6(F]2*Q=QT \D1?@'.,%(9O.
M#N&',-1MVKWML,2I"3ARLXR41 !.&(^T&;SGK#/-8Z_"\7H(-%P"Z6P.T'&4
M:.N *2&YMJ?7A/N^(5_FLYL[-1>/QJ51AJA1>4D-+E;NQR!\L [(WQ'Y7M4V
ML#H]OW_BO=#84<7=/^VTTW91^97[]'&@W7*%XP@5*R"*DQ+1F&05\?1$?&,"
M63?9856GZ],.I^O=3"9( ;-2=PL(U[E"T=-Q-XRQ\#9LPPA=<$D'US$DEB0"
M_)H ===+-0<8*\<H#B+<].J-<%I/R+E=7,*]Z6K-W+1[PJ5O,)CB,1. K95L
MW@\R,4SOT9R$Z03E9XJI*G1-06@B;9X5+J7 (7P3CTFLM(%6+45#3B8BEB#&
M)O.Z]NM\6_QS7 4/LFU>*5_WB3JCP=&&_Z\9__]REN5;\W,EDBRJ\6= QS22
M.6AD><(CL8(9 5-BF.^&PGY!Y9H8]SL(IA@R.V?;S_=W&.PY.M>=HMPB*^VQ
M@W%6)QH=7AD;10MZHR5=M##%IR*!3?B_4BK27DVV8T4.:16QF%A#:R-BE)9'
MZF]73^):FB#T%2;>FO%]F+0W:/HET?3D9C0E&YNU[32L=10.//=RLS/QN&@<
MT G*J-O*UW-&N18Z82H<*WAB[&+6LGPS-%+W[0"<,DV0C$0XL")3EI\4,'M%
MG@;TP\/F(>+P6!A[(NBGQEAN \U%*_N2Q(.V'I"I$4_E7]PF*R8",8SRVK#D
M13B1NBKBUK_3,X;V1;N3I:59CLL<I?0 LH+=?;> C/R)[R-QS/,$0!<G:FU2
M%#14HQ5^"^P[I&M%ND3#V"0K31A[>\9,<)56H?MVB8_:@?Q(R<7G4HO350-Y
MEM,,1'UG-R8:8A)A:ES*2]\-TS.F'TADMQHS%5)KT$TS1G@^Y-/,8A=R.9 O
M"A'@Q= RU(%(!9:6J!F=8="1RLK<6I,C.%H "B6-?H%^1?3* 3)@@,0X2V+G
M=@ZX?<6G,: G0';_0TNK@+_1^YDT\8'P&1OXR:HZ%H&TD1J%!?9OI#CFP9J)
MPL1ZOB8 &3,H$Z:6:^LI2B*'@OPB/CMK+'BBQ_ ,5L1!"B%: O\7? H]%Y0M
MA1/"K$@:RF2,YZ6*QDB\<4IH0C9DPLRS1J7,!M=.FQ?!R:XD?G22,"<R22#<
M0*BF/"&AT5'4A8!6T?LA+LE#2,&V.SK<L<(@)L'@K/#_QPED7SIU9Q,4>7-X
M].!KAT??)<B_[[21\\]WQ :1THTDT(6A#Q796:_89W)B%E5&XRJQT#>FI!K*
MU4'^;HA3K_853^<15C)8%\Q<U77Q;%&^6!W/GMTZV^HXQKTS0C0 YD7I\D]O
MFRO53("H%W:I%2T@I8?XIJW7!* NKMT34GX +8>4GPL2A)V:8I]@-]LU8[Q&
MIRS_+ 2H4\:6VFA2RYZ8"#42BFK#%%DB8ZO**.'+&E5/$O3?N" -)VT4H)YH
M]R66R-9Q?B0C#0+J9Z9K\-<N!C'4K69Q-C.R>T3?.>-T6B:96(EA@DS>Q#[0
MIA5=M$7;LB@U+SW6;C)Q!_[\C<I9%Y$[,X^=+:BJ,^/3KDTD I9JD<;@0[%=
M-5&R%B1LQ)EOQ%/U=..I^H;)>)<X==\SL 8.#&5 Q,$: #'P8PF$@YN: $9<
MYVA)1:LUJDW8O* 0J0CT4E,Y@+S0KH2 5SB<B(/!2M2/)^:;O,5[%<R??^WD
MZ5.18.4-BE3\PYQXB_T<L8N,O58\LO;#!GM_7QGHC-O#AD\3LW7R[,$^>DB,
M&HT-^37Q)*M-&F80N[FT R*Z)5WRD*R8]5>B4!6*UVII51K+R  Q=*>%(LL-
MXQ?$Y"-C.>2V_%PDE#;"@5^4X=0U_N?%DWP\+Z Q16 *Y.0J2V7DNVZ5>,IF
M*2#E6.8UVXKS7%6!(F@M(?4[$)%,-4PKH@Q4]DDH8!0D*I3$^:$!I]@[9S+P
MIP!B#"Q#6C?5(,L^[<).P7&YESN,#&$'0=]UV<)OJIF5*\;'^,AI/;J@LG&C
M%*T#*[B'MUZRY9'][0-O!?F3N; ">G.R!'&SK$SBH&:.U2F],\Z:J</@S&4C
M.YE)86D[C(S%(IUV.JG@I&K. %&<K$A%.8,@R69U013]:,=\U.2&>#\(\?[Q
MUL3[U.D.E]C,D]I0;C^G8CR\&%>*AD2P ,T$B0W6S%RB;SU@PG>G%:-6DBCG
M!J+KJXM)ZTA:W*'+X=/615M;UU#2PKU;N]UIS-41#(V%3P25"D4[M3MI4^"3
MOG TS*HP*(&8<!>3[S4+73:613IB]T266YJ(T;7*<7G&6G T6*.UFA<+#5KU
M$ZYL5<WYT$[(V._VTGU&>AZ4![LR@>9A5 .%[EL3/ ; 8[TP-Q9M[H3/3<3Z
M.D*.VW/2YCO, 72BJDR,:;3.0G!A/ 8AI[7Y]);;A;6LLO4-<Y2?;LU1_LA(
M]%[,3ZYJ)-5 #L> =R.YBFNA(A1VIJ8CLA%T>]O;(+P +:CJ /I#RU'3]-RB
M/.U.L0@B^A+G8E4=8 .M]PNM/]_!%NV-&8'XZJKEAK9&7SX^!TA5IK0B@$X.
M@F]3SB;^EEFR%A _I[;PVJ"]JB/[G4PD==$>7PL&\-$[K;!?6TP_C>LSA)&5
MF((21DI"-:<^.TXHD<O4V^:?1.HM-/5I&6>[TP;LHX;]ME(+1EE&.7$PJUM;
M:F^T%(54Y2)K%[)LF(J=H2K!' ?B9"YYTJR_5U^=2>4+M\ SN-KJVG2)*H+3
M63>]:J9**J 35T&&7TW2\/'6Y H':6N5W+,'I2:/RF+^C'Q;&ZOY=\9 5G5^
M/G_TQ3)_69-BF1=9NGM5O^UB4T-Q@XU?(HGW[J46SU/V1J0 F%7QQ M;L:Q;
ML4@M\_;J @I4. 2VI]HM6-0 ;2/T'600)W4$4<6ATH]"D\4.D'02*5(O_+DX
M0/R6)R(>@6 DTJB<#!3JU+TPH]-5?Z"I8TYQ@?4 S&U05H&NQI1AX122;FI?
M84I8U,'+G F?]?#AGV4\,B41$S%%N4QK'HW-DQ%7(,F.VW-)Q,CZ&6PD ?EK
M(B%0\BO8MO<GL %//V$1\&ANKJ,B@0P$MPG5!0_GW]S:M$R,0(EUUND/^#'-
M;"CBD2\QWV-CD-FGN-.VPGU02_&7JH ."'I4?MP=#-6\I%_-[@0F=UP/[$]A
MBOP7D1/[8Q3KY:!T B3Y:HR;(I*XSW%0^JDS<B*<VKI+?M\KX;E]$..K !1.
M*U"HW]-2^;$J>!$-.$+8\E^EN;7(FTZH%(JQFY#B%PFZ-*D*IU[5GE*O,-89
MR-AG5W1?DB^"9$NCA( ^ 3BYT4!(Y"$NE<U#=?88EP-7=UF:BB^8?@;(!PC7
MOHQBN^'.VR%MSXQDZJKV&P5S*6:?-G+!II.!61*)\2WBVJD4I9IB[,/B[>HN
M""<PZ[;25-WU#5TI,-5HH+LO)"W67NP"V[SZWPR!KCRBZ/9S>G#[0A![&8/M
MQ]HE9+%V)_J[R7CJOF:D<AFW-JQG3/#U+:QL&S5[I3.DH .)8O.#MXJNUS9D
M_'[-@0?[MU9N/E2A(ITDV;L-N:VP;&6!H8A1FO09](*R\B<F'21,O.77+IRD
M8>RQN65DMW,!*^BZHAAH]%JMYGYD[PD?^+SF\7=HBG9K!YRQST_T\02I#\5=
M[/UI,XD*V6P("K4;S/WJR,[GKO=K=FGBWUWT0MV'V.$[)&<< $:"0G@U7Q.V
M8!W1MB;5#-,^)F6B)1Q314Z RH.HS-4GH>V=CI3.:\(NNGS8UDCI%A!3\I7$
MM.,A4A)KP<.\I&)HA42?_V<RC>LQ2&$:83^,@J<8%XJ;Z0K<H!)J0".;E%NZ
M:D/U.R__LKG=60W0@HF&,\H&0 BX*QZ^BF3@;BX"@@-ZU(;"W3.%N_V5@A=4
M^:X2.#$LVU;#,Q=?CK"0I8UBP[,/KOSLBF.J!52@*R^.L79!%8;F:5S*(HMB
MR,5!R5&F_I]3^CIFT8K 6#"&?8"H.I36L-\*W>@*!'O'YPID7)#%47DW&/EJ
M3E=DT63,-.JEY (-[>"@YRJ=DZF>Y"[44HTC,I0CJZP"-UF<I!FF:"[:"#5D
M_&^&T-N)A>QBV78U[T]#PD7Y<#%H!7CO:F_1ZT"1%H3V8I?&A51_/#;BVU2:
M:^),74<KQP8E+CM>#0+SJ/J,O?26M@EU\'K51@>;M8-8M%&5\XXNLK.B=5S"
M!,VJB4V(% M8&C&1,U/=$EH4@B?P4*13D<"C /#0!8=1%@67L0]_Q+NK"=3@
MF\9H1U@CAHGLF&Y_3Z6Y%Y:RQ*A-0MI9KGFTU&O\J%PLSS<NEC6Y*7?#-YM\
M\_:WF%YA!8O 3D-?R0WO54QK"1Y2'A:0C%2:J.HTL4P.&J.=$0F\4%-[&>.
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M"75 :77:VA56R\=W\;U6#08.G  6QSVC A2@FMMT%!*SL.@&@M(D=X",:#F
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M+3(P,C P,C(Q7VQA8BYX;6Q02P$"% ,4    " "9C%A0\:984!\%  #K+0
M%               @ '+#   8G)O+3(P,C P,C(Q7W!R92YX;6Q02P$"% ,4
M    " "9C%A0]Z(V'C(6  !XO   $P              @ $<$@  8G)O+3AK
M7S(P,C P,C(Q+FAT;5!+ 0(4 Q0    ( )F,6%"=EHDQS"\  -C7 0 /
M          "  7\H  !B<F\M97@Q,#%?-BYH=&U02P$"% ,4    " "9C%A0
M_>0DC<,:  "^L0  #P              @ %X6   8G)O+65X,3 R7S<N:'1M
64$L%!@     &  8 ?0$  &AS      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bro-8k_20200221.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bbinsurance.com/20200221/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bro-8k_20200221.htm">bro-8k_20200221.htm</File>
    <File>bro-20200221.xsd</File>
    <File>bro-20200221_lab.xml</File>
    <File>bro-20200221_pre.xml</File>
    <File>bro-ex101_6.htm</File>
    <File>bro-ex102_7.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M_>%W%7:]L7O[CXTO@FT#O^ZB_0)02P,$%     @ F8Q84)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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MI9)]HH;#[[B[8_),[=F<W*0_"O_-+E[;V<<N+[.'"S,B]@."SA!D0F0V]B1
M40'JZ6Q&ISB=H73FZ<6,SH+U042!"Q2H0 'HBT  (I:XP (56 #Z*A" B#4N
ML$0%EH"^"00@@N2XP@I56$$^"2002.2>UZC$&O+#BX:0R#UL4(4-5"@"!02R
MP"5(CKLIAQ&6H9\0S"JB$O$L@1'6H0J"V414<.,2"B)04!L03*0Z$-S?!-J7
MTE %P;"("FYR CU,P\M',-%[P9U.H)%I6$PP3"2-"6YW MU,PXJ"82(UA>"6
M)]#0-"PK"(9%Z@K!74^@IUE861!,[,!PXQ-H:P92#&(B(A1W/H6N9F$!0S Q
M$=SX%)J:A6F,8&(BD3]LZ&D69C&&B:G@OJ?('WN8Q1@FDL44]SV%GF9A%B.8
M(LSB;-9.N7;U!U?7JM7)41K;F?G^Z2*E$39>_F0=?K,=\C2HQ<6XUY5]5T.;
M. R,[,86.)OZ\-U_4$L#!!0    ( )F,6% X87)96@(   H&   4    >&PO
M<VAA<F5D4W1R:6YG<RYX;6R%55UOVC 4?>Y^Q16;^@3DHS2#E2)1/B;4CJ*"
M5FW3'HQS2:S%=FH[!?[]'&@[*29KGI+K<X_ON3[7Z6MMH!#LJ<"1+(2Y;G2"
M!NQX)O1U(S4F_^)YFJ;(B6[+'(5=V4C%B;&?*O%TKI#$.D4T//-"WX\\3IAH
M#/J:#?IF,):TX"@,#$4,$V&8V<-,'!F8%'W/#/I>"3W"I[AN0Q@T(?1#O[KX
M#A?\&JZU482:W[69JWV.U<5NZ[8:&EIP?$B89B2IKFY(IAV6MRT6J)@LZXMA
M3(R#>U7XX>SLE,8760^8L%*+Y9L3[I#</-P_SL\_!I%_=4YX?@6'0!-F\U&[
MAG%D:U,DLPV+<0>WN*_B_/+YW N[80W#A*-*F$C@JY);D\)(\IP(A^<%/649
MPKS@:U3N3D$KN(B"7DWJ3%"I<JD.I]J$I;%M!*G@X$]EI<C8;>M=#=F*[& 6
M6_%LP^C1)Z>KNNRU_&[4Z41U90WC6*'6S=<7N&,"X5XXM82A#TM9V!8]L#C!
MK;1V&#ZC*!QDE7E4?EFE*[EU1F-,]D8* C=(:/H>T5O/%DH^,T'?W7DAM;'N
M^,GRD^V]"(.@4PT>JAW:^3^=THVJH3M)[1Z+5(HZ:X278:L7^4$U_JB8,2A*
MSW%[61T/4E=12YDQRDSIT6]6OV(DJT(6"EO4DJ#MR?%&L).."NXW&[<:!SS3
MNK#@_^6LF+'&EQLHCPEH1K139BG"VG!I)/W3A$]^._!A011\)YEKD94B<2EH
MN>=KZ<BQ<^\T 6FA#O.ZHRD1"9Z\0>8_EI-_,<_^! 9_ 5!+ P04    " "9
MC%A0NJ$YBM<!   R!@  #0   'AL+W-T>6QE<RYX;6S555N+U3 0_BLA/\"<
M=MD%I2WHPH*@LK#GP=>TG;:!W$RGQW9_O4G3V]$'\>"#OC0SWTR^^7*9-.MQ
MDO#2 2 9E=1]3CM$^XZQONI \?Z-L:!]I#%.<?2N:UEO'?"Z#Y.49.GI], 4
M%YH6F1[4D\*>5&;0F-,39476&+TC=S0"/I4K(!<N<_K(I2B=F'.Y$G**<!J
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MN]?Z@;%W^^I4TH\:X\?=_0!02P,$%     @ F8Q84/_ )@B]    A0(  !H
M  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<ZV200J#,!  OR)Y0%=MZ:&H
MIUZ\MOU T-6(FH3LENKOFWI10:$'+PEAP\Q DCRPD]P83:JQ% Q]IRD5BMG>
M *A0V$LZ&8O:3RKC>LG^Z&JPLFAEC1"'X17<DB&R9,D,\C(5+B\C$;RDJY%3
M 4,''^-:4HA,,&W1R0O\E='B/WI354V!=U.\>]2\43$+!&P'Q7,0*>FP?+)K
M=$U'AZS@>S'G10R/'1Y?,5'W])=9SUZ",*V'O\E$_37 ZM=E7U!+ P04
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MH%W\S<A'2NU!7PW_R?(+4$L! A0#%     @ F8Q84!\CSP/     $P(   L
M             ( !     %]R96QS+RYR96QS4$L! A0#%     @ F8Q84"?H
MAPZ"    L0   !               ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q0
M2P$"% ,4    " "9C%A0[5[ON^\    K @  $0              @ &9 0
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "9C%A0F5R<(Q &  "<)P
M$P              @ &W @  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( )F,6%"URY2AI0(  ),+   8              "  ?@(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "9C%A0.&%R65H"   *!@
M%               @ '3"P  >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4
M    " "9C%A0NJ$YBM<!   R!@  #0              @ %?#@  >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( )F,6% P_^1R1 $  #P"   /
M  "  6$0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "9C%A0_\ F"+T
M  "% @  &@              @ '2$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " "9C%A0"X_8 R$!  !7!   $P
M@ ''$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "@ * ( "   9%
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
